UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED: September 30, ~~2017~~2022

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: ~~________________~~333-147980

ORIGINCLEAR, INC.

(Exact name of registrant as specified in its charter)

Nevada		26-0287664
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

~~525 S. Hewitt St.~~13575 58th Street North

~~Los Angeles, CA 90013~~Suite 200

Clearwater, FL 33760

(Address of principal executive offices, Zip Code)

~~(323) 939-6645~~(727) 440-4603

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Ticker symbol(s)		Name of each exchange on which registered
N/A		N/A		N/A

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically ~~and posted on its corporate Web site, if any,~~ every Interactive Data File required to be submitted ~~and posted~~ pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit ~~and post~~ such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐☒	Smaller reporting company	☒
			Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

~~Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.~~ As of November 14, ~~2017,~~2022 there were ~~99,756,011~~936,426,610 shares of common stock, par value $0.0001 per share, issued and outstanding.

TABLE OF CONTENTS

		Page

PART I

Item 1.	Financial Statements.	1
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	1626
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	2340
Item 4.	Controls and Procedures.	2440

PART II

Item 1.	Legal Proceedings.	2541
Item 1A.	Risk Factors.	2541
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	2541
Item 3.	Defaults Upon Senior Securities.	2541
Item 4.	Mine Safety Disclosures.	2541
Item 5.	Other Information.	2541
Item 6.	Exhibits.	2542

SIGNATURES			2643

PART I - FINANCIAL INFORMATION

This Quarterly Report includes forward-looking statements within the meaning of the Securities Exchange Act of 1934 (the “Exchange Act”). These statements are based on management’s beliefs and assumptions, and on information currently available to management. Forward-looking statements include the information concerning our possible or assumed future results of operations set forth under the heading “Management’s Discussion and Analysis of Financial Condition or Plan of Operation.” Forward-looking statements also include statements in which words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “consider” or similar expressions are used.

Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions. Our future results and shareholder values may differ materially from those expressed in these forward-looking statements. Readers are cautioned not to put undue reliance on any forward-looking statements.

ITEM 1. FINANCIAL STATEMENTS

~~Item 1. Financial Statements.~~

ORIGINCLEAR, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

September 30, 2017 December 31, 2016
(Unaudited)
ASSETS

CURRENT ASSETS
Cash $ 342,164 $ 351,321
Contracts receivable, less allowance for doubtful accounts of $50,000 and $50,000 respectively 523,548 382,895
Inventory 13,614 -
Cost in excess of billing 9,238 47,612
Work in progress 84,157 86,085
Prepaid expenses 17,991 42,128

TOTAL CURRENT ASSETS 990,712 910,041

NET PROPERTY AND EQUIPMENT 156,252 161,912

OTHER ASSETS
Other asset 19,538 19,538
Goodwill 682,145 682,145
Trademark 4,467 4,467
Security deposit 3,500 3,500
TOTAL OTHER ASSETS 709,650 709,650
TOTAL ASSETS $ 1,856,614 $ 1,781,603

LIABILITIES AND SHAREHOLDERS’ DEFICIT

Current Liabilities
Accounts payable and other payable $ 830,539 $ 480,064
Accrued expenses 847,114 715,281
Billing in excess of cost 233,394 -
Customer deposit 113,950 113,950
Warranty reserve 20,000 20,000
Loans payable, current portion 11,090 -
Derivative liabilities 10,728,464 8,702,083
Convertible promissory notes, net of discount of $54,440 and $591,835, respectively 296,722 1,935,233
Total Current Liabilities 13,081,273 11,966,611

Long Term Liabilities
Loan payable, long term portion 12,282 -
Convertible promissory notes, net of discount of $235,268 and $11,429, respectively 3,080,628 1,613,571
Total Long Term Liabilities 3,092,910 1,613,571
Total Liabilities 16,174,183 13,580,182

SHAREHOLDERS’ DEFICIT
Preferred stock, $0.0001 par value, 25,000,000 shares authorized 6,666 shares of Series B issued and outstanding, respectively 1 1
1,000 shares of Series C issued and outstanding, respectively - -
Common stock, $0.0001 par value, 300,000,000 shares authorized 78,151,781 and 21,428,454 equity shares issued and outstanding, respectively 7,815 2,143
Preferred treasury stock, 1,000 and 1,000 shares of Series C outstanding, respectively - -
Additional paid in capital 57,564,158 51,428,976
Accumulated other comprehensive loss (134 ) (92 )
Accumulated deficit (71,889,409 ) (63,229,607 )
TOTAL SHAREHOLDERS’ DEFICIT (14,317,569 ) (11,798,579 )
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT $ 1,856,614 $ 1,781,603

	September 30, 2022			December 31, 2021
	(Unaudited)
ASSETS

CURRENT ASSETS
Cash	$	484,835		$	272,470
Restricted cash		1,266,391			433,951
Contracts receivable		1,946,882			2,150,967
Fair value investment in securities		45,209			198,918
Contract assets		1,455,463			378,932
Inventory assets		18,420			2,850
Prepaid expenses		10,866			13,111

TOTAL CURRENT ASSETS		5,228,066			3,451,199

NET PROPERTY AND EQUIPMENT		185,584			213,391

OTHER ASSETS
Long term assets held for sale		514,000			514,000
Fair value investment-securities		4,000			17,600
Trademark		4,467			4,467

TOTAL OTHER ASSETS		522,467			536,067

TOTAL ASSETS	$	5,936,117		$	4,200,657

LIABILITIES AND SHAREHOLDERS' DEFICIT

Current Liabilities
Accounts payable and other payable	$	2,923,241		$	1,452,229
Accrued expenses		1,591,890			1,533,404
Cumulative preferred stock dividends payable		393,228			356,728
Contract liabilities		692,570			1,886,946
Capital lease, current portion		1,169			7,985
Tax liability 83(b)		14,600			-
Customer deposit		146,453			146,453
Warranty reserve		20,000			20,000
Loan payable, merchant cash advance		30,646			80,646
Loans payable, SBA		150,000			150,000
Derivative liabilities		35,702,830			6,526,129
Series F 8% Preferred Stock, 60 and 160 shares issued and outstanding, redeemable value of $60,000 and $160,000 respectively		60,000			160,000
Series F 8% Preferred Stock, 0 and 100 shares issued and outstanding, respectively redeemable value of $0 and $100,000 respectively		-			100,000
Series G 8% Preferred Stock, 25 and 25 shares issued and outstanding, respectively, redeemable value of $25,000 and $25,000, respectively		25,000			25,000
Series I 8% Preferred Stock, 25 and 235 shares issued and outstanding, respectively, redeemable value of $25,000 and $235,000, respectively		25,000			235,000
Series K 8% Preferred Stock, 432.15 and 580.65 shares issued and outstanding, respectively, redeemable value of $432,150 and $580,650, respectively		432,150			580,650
Convertible promissory notes, net of discount of $0 and $3,743, respectively		878,283			3,016,037

Total Current Liabilities		43,087,060			16,277,207

Long Term Liabilities
Capital lease, long term portion		-			-
Convertible promissory notes, net of discount of $0 and $0, respectively		2,048,472			62,275

Total Long Term Liabilities		2,048,472			62,275

Total Liabilities		45,135,532			16,339,482

COMMITMENTS AND CONTINGENCIES (See Note 11)		-			-

Series J Convertible Preferred Stock, 210 and 215 shares of issued and outstanding, respectively, redeemable value of $210,000 and $215,000, respectively		210,000			215,000
Series L Convertible Preferred Stock, 325.75 and 609.825 shares of issued and outstanding, respectively redeemable value of 325,750 and 609.825, respectively		325,750			609,825
Series M Preferred Stock, 40,300 and 40,300 shares issued and outstanding, respectively, redeemable value of $1,007,500 and $1,007,500, respectively		1,007,500			1,007,500
Series O 8% Convertible Preferred Stock, 590 and 615 shares issued and outstanding, respectively, redeemable value of $590,000 and $615,000, respectively		590,000			615,000
Series P Convertible Preferred Stock, 30 and 57.5 shares issued and outstanding, respectively redeemable value of $30,000 and $57,500, respectively		30,000			57,500
Series Q 12% Convertible Preferred Stock, 615 and 515 shares issued and outstanding, respectively, redeemable value of $615,000 and $515,000, respectively		615,000			515,000
Series R 12% Convertible Preferred Stock,2,828 and 3,432.267 shares issued and outstanding, respectively, redeemable value of $2,828,000 and $3,432,267, respectively		2,828,000			3,432,267
Series S 12% Convertible Preferred Stock, 170 and 170 shares issued and outstanding, respectively, redeemable value of $170,000 and $170,000, respectively		170,000			170,000
Series T 10% Convertible Preferred Stock, 18 and 630, respectively, redeemable value of $18,000 and $630,000, respectively		18,000			630,000
Series U Convertible Preferred Stock, 485 and 1,066.5, respectively, redeemable value of $485,000 and $1,066,500, respectively		485,000			1,066,500
Series V Convertible Preferred Stock, 0 and 4, respectively, redeemable value of $0 and $400,000, respectively		-			400,000
Series W 12% Convertible Preferred Stock, 794.5 and 744.5, respectively, redeemable value of $794,500 and $744,500, respectively		794,500			744,500
Series X Convertible Preferred Stock, 250 and 250, respectively, redeemable value of $250,000 and $250,000, respectively		250,000			250,000
Series Y Convertible Preferred Stock, 37.09277 and 4.7, respectively, redeemable value of $3,709,277and $470,000, respectively		3,709,277			470,000
Series Z Convertible Preferred Stock, 25 and 0, respectively, redeemable value of $250,000 and $0, respectively		250,000			-
		11,283,027			10,183,092

SHAREHOLDERS' DEFICIT
Preferred stock, $0.0001 par value, 550,000,000 shares authorized 1,000 shares of Series C issued and outstanding, respectively		-			-
31,500,000 and 32,500,000 shares of Series D-1 issued and outstanding, respectively		3,150			3,150
0 and 1,537,213 shares of Series E issued and outstanding, respectively		-			154
Subscription payable to purchase		100,000			100,000
Preferred treasury stock,1,000 and 1,000 shares outstanding, respectively		-			-
Common stock, $0.0001 par value, 16,000,000,000 shares authorized 900,109,842 and 306,883,932 equity shares issued and outstanding, respectively		90,011			30,688
Additional paid in capital - Common stock		81,394,700			75,720,147
Accumulated other comprehensive loss		(132	)		(132	)
Accumulated deficit		(132,070,171	)		(98,175,924	)

TOTAL SHAREHOLDERS' DEFICIT		(50,482,442	)		(22,321,917	)

TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$	5,936,117		$	4,200,657

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

ORIGINCLEAR, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER ~~30, 2017~~30,2022 AND ~~2016~~2021

(Unaudited)

Three Months Ended Nine Months Ended
September 30, 2017 September 30, 2016 September 30, 2017 September 30, 2016

Sales $ 1,112,438 $ 1,019,919 $ 2,294,891 $ 4,321,378

Cost of Goods Sold 949,657 574,105 2,031,334 2,899,507

Gross Profit 162,781 445,814 263,557 1,421,871

Operating Expenses
Selling and marketing expenses 539,975 303,496 2,165,213 1,419,566
General and administrative expenses 830,444 629,455 1,842,815 1,860,239
Research and development 53,939 106,259 136,582 447,034
Depreciation and amortization expense 12,961 11,331 39,506 33,902

Total Operating Expenses 1,437,319 1,050,541 4,184,116 3,760,741

Loss from Operations (1,274,538 ) (604,727 ) (3,920,559 ) (2,338,870 )

OTHER INCOME (EXPENSE)
Foreign exchange (loss) - (6 ) - (6 )
Commitment fee (736,052 ) (787,971 ) (1,409,655 ) (787,971 )
Loss on net change in derivative liability and settlement of debt (2,693,599 ) (7,417,750 ) (2,787,138 ) (1,959,230 )
Interest expense (173,448 ) (206,164 ) (542,450 ) (641,977 )

TOTAL OTHER INCOME (EXPENSE) (3,603,099 ) (8,411,891 ) (4,739,243 ) (3,389,184 )

NET (LOSS) INCOME $ (4,877,637 ) $ (9,016,618 ) $ (8,659,802 ) $ (5,728,054 )

BASIC AND DILUTED (LOSS) EARNING PER SHARE ATTRIBUTABLE TO SHAREHOLDERS’ $ (0.090 ) $ (0.657 ) $ (0.222 ) $ (0.492 )

WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, BASIC AND DILUTED 54,334,415 13,724,144 38,977,842 11,644,611

	Three Months Ended						Nine Months Ended
	September 30, 2022			September 30, 2021			September 30, 2022			September 30, 2021

Sales	$	3,366,061		$	1,120,687		$	7,768,133		$	2,848,287

Cost of Goods Sold		2,542,887			790,336			6,484,235			2,237,282

Gross Profit		823,174			330,351			1,283,898			611,005

Operating Expenses
Selling and marketing expenses		712,420			636,481			1,825,170			2,201,045
General and administrative expenses		1,085,044			1,006,041			2,900,203			2,785,713
Depreciation and amortization expense		10,204			10,903			31,446			34,034

Total Operating Expenses		1,807,668			1,653,425			4,756,819			5,020,792

Loss from Operations		(984,494	)		(1,323,074	)		(3,472,921	)		(4,409,787	)

OTHER INCOME (EXPENSE)
Other income		-			356,438			-			359,939
Impairment of asset for sale		-			(116,000	)		-			(116,000	)
Gain on write of loans payable		-			151,000			75,000			157,250
Gain (Loss) on conversion of preferred stock		(188,395	)		(146,382	)		(434,380	)		(1,265,666	)
Loss on exchange of preferred stock		-			-			-			(40,000	)
Unrealized gain(loss) on investment securities		(24,604	)		(8,400	)		(167,309	)		32,000
Cash settlement for non-conversion of common stock		(13,500	)		-			(13,500	)		-
Gain (Loss) on net change in derivative liability and conversion of debt		(27,607,804	)		19,798,080			(29,176,702	)		(4,146,757	)
Interest and dividend expense		(233,426	)		(314,547	)		(704,434	)		(934,942	)

TOTAL OTHER (EXPENSE) INCOME		(28,067,729	)		19,720,189			(30,421,325	)		(5,954,176	)

NET INCOME (LOSS)	$	(29,052,223	)	$	18,397,115		$	(33,894,246	)	$	(10,363,963	)

WARRANTS DEEMED DIVIDENDS		-			-			-			(2,037,849	)

NET (LOSS) ATTRIBUTABLE TO SHAREHOLDERS INCOME	$	(29,052,223	)	$	18,397,115		$	(33,894,246	)	$	(12,401,812	)

BASIC EARNINGS (LOSS) PER SHARE ATTRIBUTABLE TO SHAREHOLDERS'	$	(0.04	)	$	0.09		$	(0.06	)	$	(0.08	)

DILUTED EARNINGS (LOSS) PER SHARE ATTRIBUTABLE TO SHAREHOLDERS'	$	(0.04	)	$	0.02		$	(0.06	)	$	(0.08	)

WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING,
BASIC		775,597,578			197,669,804			589,675,480			147,762,596

DILUTED		775,597,578			795,174,058			589,675,480			147,762,596

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

ORIGINCLEAR, INC. AND SUBSIDIARIES

~~CONDENSED~~ CONSOLIDATED ~~STATEMENT~~STATEMENTS OF ~~SHAREHOLDERS’~~SHAREHOLDERS' DEFICIT

FOR THE NINE MONTHS ENDED SEPTEMBER 30, ~~2017~~2022 AND 2021

Additional Accumulated
Other
Preferred stock Common stock Paid-in Comprehensive Accumulated
Shares Amount Shares Amount Capital loss Deficit Total
Balance at December 31, 2016 7,666 $ 1 21,433,571 $ 2,143 $ 51,428,976 $ (92 ) $ (63,229,607 ) $ (11,798,579 )

Common stock issuance for cash - - 10,775,722 1,078 1,296,672 - - 1,297,750

Common stock issuance for conversion of debt - - 9,321,555 932 1,234,040 - - 1,234,972

Common stock issuance for settlement of accounts payable - - 886,700 89 117,842 - - 117,931

Common stock issued at fair value for services and commitment fees - - 35,734,233 3,573 3,415,025 - - 3,418,598

Stock compensation cost - - - - 71,603 - - 71,603

Other comprehensive loss - - - - - (42 ) - (42 )

Net loss for the nine months ended September 30, 2017 - - - - - - (8,659,802 ) (8,659,802 )

Balance at September 30, 2017 (unaudited) 7,666 $ 1 78,151,781 $ 7,815 $ 57,564,158 $ (134 ) $ (71,889,409 ) $ (14,317,569 )

	NINE MONTHS ENDED SEPTEMBER 30, 2021
																				Accumulated
	Preferred stock						Mezzanine			Common stock					Additional Paid-in-			Subscription		Other Comprehensive			Accumulated
	Shares			Amount			Equity			Shares		Amount			Capital			Payable		loss			Deficit			Total
Balance at December 31, 2020		34,038,213		$	3,404		$	6,331,409			65,052,688	$	6,505		$	64,265,217		$	100,000	$	(132	)	$	(94,020,294	)	$	(29,645,300	)
Rounding		-			-			-			-		(1	)		(1	)		-		-			-			(3	)
Common stock issuance for conversion of debt and accrued interest		-			-			-			13,927,622		1,393			132,312			-		-			-			133,705
Common stock issued at fair value for services		-			-						24,656,117		2,466			1,927,258			-		-			-			1,929,724
Common stock issued for conversion of Series D1 Preferred stock		(1,000,000	)		(100	)		-			68,571		7			5,547			-		-			-			5,454
Common stock issued for conversion of Series J Preferred stock		-			-			(47,500	)		1,203,924		120			47,380			-		-			-			47,500
Common stock issued for conversion of Series L Preferred stock		-			-			(472,759	)		15,265,754		1,527			471,232			-		-			-			472,759
Common stock issued for Series O Preferred stock dividends		-			-			-			495,366		50			(50	)		-		-			-			-
Common stock issued for conversion of Series O Preferred stock		-			-			(1,060,000	)		27,357,198		2,736			1,057,264			-		-			-			1,060,000
Common stock issued for conversion of Series P Preferred stock		-			-			(280,250	)		9,086,985		909			279,341			-		-			-			280,250
Common stock issued for make good shares for Series P Preferred stock		-			-			-			633,282		63			(63	)		-		-			-			-
Common stock issued for conversion of Series Q Preferred stock		-			-			(420,000	)		10,668,656		1,067			418,933			-		-			-			420,000
Common stock issued for conversion of Series R Preferred stock		-			-			(1,084,900	)		33,520,261		3,352			1,081,548			-		-			-			1,084,900
Common stock issued for conversion of Series S Preferred stock		-			-			(195,000	)		5,495,406		550			194,450			-		-			-			195,000
Common stock issued in conjunction with the sale of Series X Preferred stock		-			-			-			1,798,562		180			(180	)		-		-			-			-
Common stock issued for conversion of Series U Preferred stock		-			-			(330,000	)		8,729,034		873			329,127			-		-			-			330,000
Common stock issued for conversion of Series W Preferred stock		-			-			(245,500	)		7,020,764		702			244,798			-		-			-			245,500
Issuance of Series M Preferred stock through a private placement		-			-			29,425			-		-			-			-		-			-			-
Issuance of Series R Preferred stock through a private placement		-			-			2,480,750			-		-			-			-		-			-			-
Issuance of Series T Preferred stock in exchange for property		-			-			630,000			-		-			-			-		-			-			-
Issuance of Series U Preferred stock in exchange for property		-			-			965,000			-		-			-			-		-			-			-
Issuance of Series X Preferred stock through a private placement		-			-			250,000			-		-			-			-		-			-			-
Exchange of Series F Preferred Stock for Series Q Preferred stock		-			-			15,000			-		-			-			-		-			-			-
Exchange of Series G Preferred Stock for Series R Preferred stock		-			-			15,000			-		-			-			-		-			-			-
Exchange of Series G Preferred Stock for Series S Preferred stock		-			-			365,000			-		-			-			-		-			-			-
Exchange of Series I Preferred Stock for Series R Preferred stock		-			-			317,400			-		-			-			-		-			-			-
Exchange of Series I Preferred Stock for Series W Preferred stock		-			-			245,000			-		-			-			-		-			-			-
Exchange of Series K Preferred Stock for Series R Preferred stock		-			-			1,821,767			-		-			-			-		-			-			-
Exchange of Series K Preferred Stock for Series W Preferred stock		-			-			758,000			-		-			-			-		-			-			-
Exchange of Series M Preferred Stock for Series R Preferred stock		-			-			40,000			-		-			-			-		-			-			-
Warrants purchased for cash		-			-			-			1,000,000		100			49,900			-		-			-			50,000
Loss on issuance of Preferred Stock		-			-			-			-		-			125,000			-		-						125,000
Loss on conversion of Preferred Stock		-			-			-			-		-			1,140,666			-		-			-			1,140,666
Issuance of common stock warrants deemed dividends		-			-			-			-		-			2,037,849			-		-			(2,037,849	)		-
Adjustment to Series L Preferred stock		-			-			500			-		-			(500	)		-		-			-			(500	)
Stock based compensation		-			-			-			-		-			62,480			-		-			-			62,480
Net Loss		-			-			-			-		-			-			-		-			(10,363,963	)		(10,363,963	)
Balance at September 30, 2021 (unaudited)		33,038,213		$	3,304			10,128,342			225,980,190	$	22,598		$	73,869,508		$	100,000	$	(132	)	$	(106,422,106	)	$	(32,426,829	)

ORIGINCLEAR, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021

	NINE MONTHS ENDED SEPTEMBER 30, 2022
	Preferred stock						Mezzanine			Common stock						Additional			Subscription		Other Comprehensive			Accumulated
	Shares			Amount			Equity			Shares			Amount			Capital			Payable		loss			Deficit			Total

Balance at December 31, 2021		33,038,213			3,304		$	10,183,092			306,883,932			30,688			75,720,147			100,000		(132	)		(98,175,924	)		(22,321,917	)
Rounding		-			-			5			-			-			-			-		-			(1	)		(1	)
Common stock issuance for conversion of debt and accrued interest		-			-			-			39,900,514			3,990			266,556			-		-			-			270,546
Common stock issued at fair value for services		-			-			-			41,046,848			4,105			1,050,844			-		-			-			1,054,949
Common stock issued for conversion of Series E Preferred stock		(1,537,213	)		(154	)		-			76,865			7			147			-		-			-			-
Common stock issued for conversion of Series J Preferred stock		-			-			(5,000	)		512,737			51			4,949			-		-			-			5,000
Common stock issued for conversion of Series L Preferred stock		-			-			(284,080	)		25,145,849			2,515			281,565			-		-			-			284,080
Common stock issued for conversion of Series O Preferred stock		-						(25,000	)		1,258,812			126			24,874			-		-			-			25,000
Common stock issued for conversion of Series P Preferred stock		-						(27,500	)		3,527,317			353			27,147			-		-			-			27,500
Common stock issued for conversion of Series Q Preferred stock		-						(100,000	)		12,642,226			1,264			98,736			-		-			-			100,000
Common stock issued for conversion of Series R Preferred stock		-			-			(604,267	)		44,494,096			4,449			599,818			-		-			-			604,267
Common stock issued for conversion of Series T Preferred stock		-			-			(612,000	)		83,105,450			8,311			603,689			-		-			-			612,000
Common stock issued for conversion of Series U Preferred stock		-			-			(581,500	)		30,629,247			3,063			578,437			-		-			-			581,500
Common stock issued for conversion of Series W Preferred stock		-			-			(245,000	)		21,489,284			2,149			242,851			-		-			-			245,000
Common stock issued for conversion of Series Y Preferred stock		-			-			(1,500,000	)		108,238,078			10,824			1,489,176			-		-			-			1,500,000
Common stock issued for Series O Preferred stock dividends		-			-			-			917,821			92			(92	)		-		-			-			-
Common stock issued for make good shares for Series P Preferred Stock		-			-			-			518,232			52			(52	)		-		-			-			-
Common stock issued for make good shares for Series R Preferred Stock		-			-			-			1,041,662			104			(104	)		-		-			-			-
Common stock issued for conversion settlement		-			-			-			179,090,390			17,909			(17,909	)		-		-			-			-
Common stock returned for non conversion		-			-			-			(409,518	)		(41	)		(10,459	)		-		-			-			(10,500	)
Issuance of Series Y Preferred stock through a private placement		-			-			4,339,277			-			-			-			-		-			-			-
Issuance of Series Z Preferred stock through a private placement		-			-			250,000			-			-			-			-		-			-			-
Exchange of Series F Preferred Stock for Series Q Preferred stock		-			-			200,000			-			-			-			-		-			-			-
Exchange of Series I Preferred Stock for Series W Preferred stock		-			-			210,000			-			-			-			-		-			-			-
Exchange of Series K Preferred Stock for Series W Preferred stock		-			-			85,000			-			-			-			-		-			-			-
Exchange of Series V Preferred Stock for Series Y Preferred stock		-			-			-			-			-			-			-		-			-			-
Loss on conversion of Preferred Stock		-			-			-			-			-			434,380			-		-			-			434,380
Net Loss		-			-			-			-			-			-			-		-			(33,894,246	)		(33,894,246	)
Balance at September 30, 2022 (unaudited)		31,501,000		$	3,150		$	11,283,027			900,109,842		$	90,011		$	81,394,700		$	100,000	$	(132	)	$	(132,070,171	)	$	(50,482,442	)

The accompany notes are an integral part of these ~~unaudited condensed~~audited consolidated financial statements

ORIGINCLEAR, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021

(Unaudited)

Nine Months Ended
September 30, 2017 September 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss $ (8,659,802 ) $ (5,728,054 )
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation and amortization 39,506 33,902
Common stock and warrants issued for services 3,418,598 1,787,902
Stock option and warrant compensation expense 71,603 155,112
Loss on net change in valuation of derivative liability and conversion of debt 2,787,138 1,959,230
Debt discount and original issue discount recognized as interest expense 313,546 373,434
Change in Assets (Increase) Decrease in:
Contracts receivable (140,653 ) 675,188
Cost in excess of billing 38,374 (12,954 )
Inventory asset (13,614 ) -
Prepaid expenses 24,137 1,797
Work in progress 1,928 518
Other asset - (88,548 )
Change in Liabilities Increase (Decrease) in:
Accounts payable 468,406 299,584
Accrued expenses 121,047 257,501
Billing in excess of cost 209,294 (474,741 )
Deferred income 24,100 (150,000 )

NET CASH USED IN OPERATING ACTIVITIES (1,296,392 ) (910,129 )

CASH FLOWS USED FROM INVESTING ACTIVITIES:
Purchase of fixed assets (33,845 ) (5,699 )

CASH USED IN INVESTING ACTIVITIES (33,845 ) (5,699 )

CASH FLOWS FROM FINANCING ACTIVITIES:
Loans payable 23,372 -
Proceeds from convertible promissory notes - 125,000
Proceeds for issuance of common stock for cash 1,297,750 963,217

NET CASH PROVIDED BY FINANCING ACTIVITIES 1,321,122 1,088,217

Foreign currency effect on cash flow (42 ) (23 )

NET (DECREASE) INCREASE IN CASH (9,157 ) 172,366

CASH BEGINNING OF PERIOD 351,321 695,295

CASH END OF PERIOD $ 342,164 $ 867,661

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid $ 1,823 $ 2,199
Taxes paid $ - $ -

SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Common stock issued at fair value for conversion of debt and accrued interest $ 1,234,972 $ 878,040
Common stock issued at fair value on settlement of accounts payable $ 117,931 $ -
Common stock issued at fair value for supplemental shares $ 1,409,655 $ 787,971
Beneficial conversion feature on convertible note
$ - $ 16,771
Conversion of accounts payable into a convertible note $ - $ 430,896

	Nine Months Ended
	September 30, 2022			September 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (loss)	$	(33,894,246	)	$	(10,363,963	)
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation and amortization		31,446			34,034
Stock compensation expense		-			62,480
Common and preferred stock issued for services		1,054,949			1,929,724
(Gain) Loss on net change in valuation of derivative liability		29,176,702			4,146,757
Debt discount recognized as interest expense		3,743			52,288
Net unrealized (gain)loss on fair value of securities		167,309			(32,000	)
Loss on exchange of preferred stock		-			40,000
Loss on issuance of preferred stock		-			125,000
SBA loan forgiven		-			(355,000	)
Impairment of assets held for sale		-			116,000
(Gain) Loss on conversion of preferred stock		434,380			1,140,666
Gain on write off of payable		(50,000	)		(157,250	)
Change in Assets (Increase) Decrease in:
Contracts receivable		204,085			(273,576	)
Contract asset		(1,076,532	)		76,873
Inventory asset		(15,570	)		(2,850	)
Prepaid expenses and other assets		2,245			20,498
Other receivable		-			1,200
Change in Liabilities Increase (Decrease) in:
Accounts payable		1,509,505			(372,641	)
Accrued expenses		173,737			53,572
Tax liability 83(b)		14,600			-
Contract liabilities		(1,194,376	)		198,155

NET (CASH USED)/PROVIDED BY OPERATING ACTIVITIES		(3,458,023	)		(3,560,033	)

CASH FLOWS USED FROM INVESTING ACTIVITIES:
Purchase of fixed assets		(17,138	)		(13,500	)

NET CASH USED IN INVESTING ACTIVITIES		(17,138	)		(13,500	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on capital lease		(6,816	)		(6,816	)
Repayment of loans, net		-			(105,000	)
Repayment of loans, related party, net		-			(94,883	)
Net payments on cumulative preferred stock dividends payable		36,500			102,993
Proceeds on convertible promissory notes		-			60,000
Payoff on convertible promissory notes		-			(15,228	)
Proceeds for the purchase of warrants		-			50,000
Return of investment and common shares		(10,500	)		-
Net proceeds for issuance of preferred stock for cash - mezzanine classification		4,525,782			3,725,175

NET CASH PROVIDED BY FINANCING ACTIVITIES		4,544,966			3,716,241

NET INCREASE IN CASH		1,044,805			142,708

CASH BEGINNING OF PERIOD		706,421			416,121

CASH END OF PERIOD	$	1,751,226		$	558,829

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest and dividends paid	$	828,638		$	3,741
Taxes paid	$	-		$	-

SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Common stock issued at fair value for conversion of debt, plus accrued interest, and other fees	$	270,546		$	133,705
Issuance of Series T preferred shares in exchange for property	$	-		$	630,000
Issuance of Series O dividends	$	92		$	50
Preferred stock converted to common stock - mezzanine	$	3,984,347		$	4,135,909
Exchange from mezzanine to liability	$	495,000		$	3,537,167
Issuance of warrants deemed dividends	$	-		$	2,037,849
Fair value of derivative at issuance	$	-		$	54,652
Common stock issued as settlement	$	17,884		$	-

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

ORIGINCLEAR, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS-UNAUDITED

SEPTEMBER 30, ~~2017~~2022

~~The accompanying unaudited condensed financial statements~~Basis of OriginClear, Inc. (the “Company”) (formerly OriginOil, Inc.) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. For further information refer to the financial statements and footnotes thereto included in the Company’s Form 10-K for the year ended December 31, 2016.Presentation

~~Going Concern~~

The accompanying unaudited condensed consolidated financial statements of OriginClear, Inc. (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. For further information refer to the financial statements and footnotes thereto included in the Company’s Form 10-K for the year ended December 31, 2021.

The Company has implemented a new outsourced water treatment business called Water On Demand (“WOD”), which it will conduct through its wholly owned subsidiary, Water on Demand, Inc. (“WODI”). The WOD model intends to offer private businesses water self-sustainability as a service, the ability to pay for water treatment and purification services on a per-gallon basis. This is commonly known as Design-Build-Own-Operate or “DBOO”. In addition to WODI, four subsidiaries have been established to house capital dedicated to this program. For efficiency, the Company is reorganizing these subsidiaries into a single WOD Subsidiary. As of the period ended September 30, 2022, the Company received aggregate funding in the amount of $2,604,639 through the sale of its Series Y Preferred Stock dedicated to the Water on Demand program. The Company is currently evaluating the first pilot opportunity to enable a commercial customer to outsource water treatment as a managed service and pay by the gallon for the treatment of its dirty water as an alternative to having to come up with significant up-front capital. The Company has announced that it plans to spin off the WOD business into its newly formed wholly owned subsidiary, Water On Demand, Inc.

Going Concern

The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying ~~condensed~~ financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. ~~The Company’s revenue is not yet sufficient to cover its operating expenditures and has negative cash flows from operations, which~~These factors, among others raise substantial doubt about the Company’s ability to continue as a going concern. Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2021 expressed substantial doubt about our ability to continue as a going concern.

The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, achieving a level of profitable operations and receiving additional cash ~~infusion.~~infusions. During the nine months ended September 30, 2022, the Company obtained funds from the sales of its preferred stock. Management believes this funding will continue from its’ current investors and from new investors. For the nine months ended September 30, 2022, the Company generated revenue of $7,768,133 and has standing purchase orders and open invoices with customers, which will provide funds for operations. Management believes the existing shareholders, the prospective new investors ~~current~~ and future sales will provide the additional cash needed to meet the Company’s obligations as they become due and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain ~~undue~~ restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders, in case of equity financing.

2.	SUMMARY OF SIGNIFICANT ACCOUNTING POLICES

This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., Water On Demand, Inc. and OriginClear ~~(HK) Company,~~Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities.

Cash and Cash Equivalent

~~Loss~~

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Net Earnings (Loss) per Share Calculations

Basic loss per share ~~calculations are~~calculation is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed ~~similar~~similarly to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.

The ~~Company has excluded 3,697,495 of stock options, 474,335 warrants, and~~Company’s diluted earnings per share were not the ~~shares issuable from convertible debt of $3,667,068 and shares issuable from convertible preferred stock~~same as the basic loss per share for the nine months ended September 30, ~~2017, because~~2022 and 2021, as the inclusion of any potential shares in the nine months ended September 30, 2022 and 2021, would have an anti-dilutive effect due to the Company generating a loss.

	For the Nine Months Ended
	2022			2021
Income (Loss) to common shareholders (Numerator)	$	(33,894,246	)	$	(12,401,812	)

Basic weighted average number of common shares outstanding (Denominator)		589,675,480			147,762,596

Diluted weighted average number of common shares outstanding (Denominator)		589,675,480			147,762,596

The Company excludes issuable shares from warrants, convertible notes and preferred stock, if their impact on the loss per share is ~~anti-dilutive.~~anti-dilutive and includes the issuable shares if their impact is dilutive.

Revenue Recognition

We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured.

Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined.

Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined.

Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs.

Contract Receivable

The Company ~~has excluded 113,916,311 stock options, 17,824,259 warrants,~~bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients’ financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the ~~shares issuable~~potential for recovery is considered remote. The allowance for doubtful accounts was $0 and $0 as of September 30, 2022 and December 31, 2021, respectively. The net contract receivable balance was $1,946,882 and $2,150,967 at September 30, 2022 and December 31, 2021, respectively.

Prepaid Expenses

The Company records expenditures that have been paid in advance as prepaid expenses. The prepaid expenses are initially recorded as assets, because they have future economic benefits, and are expensed at the time the benefits are realized. The prepaid expenses balance was $10,866 and $13,111 at September 30, 2022 and December 31, 2021, respectively.

Indefinite Lived Intangibles and Goodwill Assets

The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations,” where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from ~~convertible debt~~acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of ~~$4,214,068~~the fair value of the tangible and ~~shares issuable~~identified intangible assets acquired less liabilities assumed is recognized as goodwill.

The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles and goodwill at September 30, 2022 and determined there was no impairment of indefinite lived intangibles and goodwill.

Property and Equipment

Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from ~~convertible preferred stock~~the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and betterment are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories:

Estimated Life
Machinery and equipment			5-10 years
Furniture, fixtures and computer equipment			5-7 years
Vehicles			3-5 years
Leasehold improvements			2-5 years

	Nine Months Ended 9/30/2022			Year Ended 12/31/21
Machinery and Equipment	$	383,570		$	383,570
Computer Equipment		66,491			62,854
Furniture		29,810			29,810
Leasehold Improvements		26,725			26,725
Vehicles		64,277			64,277
Demo Units		36,139			36,139
		607,012			603,375
Less accumulated depreciation		(421,428	)		(389,984	)
Net Property and Equipment	$	185,584		$	213,391

Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that the facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability would be performed following generally accepted accounting principles.

Depreciation expense during the nine months ended September 30, ~~2016, because their impact on the earnings per share is anti-dilutive.~~2022 and 2021, was $31,446 and $34,034, respectively.

~~Work-in-Process~~Inventory

The Company ~~recognizes~~expenses inventory on a first in, first out basis, and had raw materials of $18,420 and $2,850 as ~~an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price~~ of ~~materials~~September 30, 2022 and ~~labor related to the construction of equipment to be sold to customers.~~December 31, 2021, respectively.

Stock-Based Compensation

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants ~~are~~vest immediately ~~vested~~ and the total stock-based compensation charge is recorded in the period of the measurement date.

Accounting for Derivatives

The Company evaluates all its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice option pricing models to value the derivative instruments at inception and on subsequent valuation dates.

~~ORIGINCLEAR, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS-UNAUDITED~~

~~SEPTEMBER 30, 2017~~

2.	~~SUMMARY OF SIGNIFICANT ACCOUNTING POLICES (Continued)~~

~~Revenue Recognition~~

~~Equipment sales~~

~~We recognize revenue upon delivery~~The classification of ~~equipment, provided that evidence~~derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of ~~an arrangement exists, title, and risk of loss have passed to~~each reporting period. Derivative instrument liabilities are classified in the ~~customer, fees are fixed~~balance sheet as current or ~~determinable, and collection~~non-current based on whether or not the net-cash settlement of the related receivable is reasonably assured. Title to the equipment is transferred to the customer once the last payment is received. We record revenue as goods are shipped, and the equipment has been fully accepted by the customer. Generally, we extend credit to our customers and do not require collateral. We do not ship a product until we have a purchase agreement signed by the customer with a payment arrangement.

~~Percentage of completion~~

~~Revenues and related costs on construction contracts are recognized using the “percentage of completion method” of accounting in accordance with ASC 605-35 – “~~~~Accounting for Performance of Construction-Type and Certain Production Type Contracts”.~~~~Under this method, contract revenues and related expenses are recognized over the performance period~~derivative instrument could be required within 12 months of the contract in direct proportion to the costs incurred as a percentage of total estimated costs for the entirety of the contract. Costs include direct material, direct labor, subcontract labor and any allocable indirect costs. All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined.

The asset “Costs in excess of billings” represents revenues recognized in excess of amounts billed on contracts in progress. The liability “Billings in excess of costs” represents billings in excess of revenues recognized on contracts in progress. Assets and liabilities related to long-term contracts are included in current assets and current liabilities in the accompanying balance sheets, as they will be liquidated in the normal course of the contract completion. The cost in excess of billings for the nine months ending September 30, 2017 was $9,238 and at December 31, 2016 was $47,612. The billing in excess of cost for the nine months ending September 30, 2017, was $209,294 and at December 31, 2016 was $0.

~~Contract Receivable~~

The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was approximately $50,000 as of September 30, 2017 and December 31, 2016, respectively. The net contract receivable balance was $523,548 and $382,895 at September 30, 2017 and December 31, 2016, respectively.sheet date.

~~ORIGINCLEAR, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS-UNAUDITED~~

~~SEPTEMBER 30, 2017~~

2.	~~SUMMARY OF SIGNIFICANT ACCOUNTING POLICES (Continued)~~

Fair Value of Financial Instruments

Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not to recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, ~~2017,~~2022, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities.

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

●

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

●
	●	Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

●	●	Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of September 30, ~~2017.~~2022.

Total (Level 1) (Level 2) (Level 3)

Derivative Liability $ 10,728,464 $ - $ - $ 10,728,464

Total liabilities measured at fair value $ 10,728,464 $ - $ - $ 10,728,464

	Total		(Level 1)		(Level 2)		(Level 3)
Investment at fair value-securities	$	45,209	$	45,209	$	-	$	-
Total Assets measured at fair value	$	45,209	$	45,209	$	-	$	-

		Total		(Level 1)		(Level 2)		(Level 3)
Derivative Liability, convertible notes	$	34,083,579	$	-	$	-	$	34,083,579
Derivative Liability, warrants	$	1,619,251	$	-	$	-	$	1,619,251
Total liabilities measured at fair value	$	35,702,830	$	-	$	-	$	35,702,830

The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value:

Balance as of January 1, 2017 $ 8,702,083
Fair Value of derivative liabilities issued -
Change in derivative liability, excluding loss on settlement of debt 2,026,381
Balance as of September 30, 2017 10,728,464

Balance as of January 1, 2022	$	6,526,129
Fair value at issuance		-
Loss on conversion of debt and change in derivative liability		27,557,450
Balance as of September 30, 2022	$	34,083,579

For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows:

	~~09/30/2017~~September 30, 2022
Risk free interest rate		~~.01%~~2.79% - ~~1.92~~4.22 %	%
Stock volatility factor		~~4.72%~~20.0% - ~~189.09~~185.0 %	%
Weighted average expected option life		6 months - 5 years
Expected dividend yield		None

~~ORIGINCLEAR, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS-UNAUDITED~~

~~SEPTEMBER 30, 2017~~Segment Reporting

2.	~~SUMMARY OF SIGNIFICANT ACCOUNTING POLICES (Continued)~~

~~Segment Reporting~~

The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated.

Marketable Securities

The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income.

Licensing agreement

The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered.

Work-in-Process

The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers.

Reclassification of Expenses and Income

Certain amounts in the 2021 financial statements have been reclassified to conform to the presentation used in the 2022 financial statements. There was no material effect on the Company’s previously issued financial statements.

Recently Issued Accounting Pronouncements

In February 2016, the FASB issued ASU No. 2016-2, which creates ASC Topic 842, “Leases.” This update increases transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. This guidance is effective for interim and annual reporting periods beginning after December 15, 2018. We are evaluating what impact, if any, the adoption of this guidance will have on our financial condition, results of operations, cash flows or financial disclosures.

In August 2016, the FASB issued ASU No. 2016-15 which amends ASC Topic 230, “Classification of Certain Cash Receipts and Cash Payments.” The amendments in this Update address eight specific cash flow issues with the objective of reducing the existing diversity in practice. The update outlines the classification of specific transactions as either cash inflows or outflows from financing activities, operating activities, investing activities or non-cash activities. This guidance is effective for interim and annual reporting periods beginning after December 15, 2017. We are evaluating what impact, if any, the adoption of this guidance will have on our financial condition, results of operations, cash flows or financial disclosures.

In May 2017, FASB issued accounting standards update ASU-2017-09, “Compensation-Stock Compensation” (Topic 718) –Modification Accounting”, to provide clarity and reduce both (1) diversity in practice and (2) cost and complexity when applying the guidance in Topic 718, Compensation-Stock Compensation, to a change to the terms or conditions of a share-based payment award. The amendments in this ASU are effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017. Early adoption is permitted, including adoption in an interim period for public entities for reporting periods for which financial statements have not yet been issued, and all other entities for reporting periods for which financial statements have not yet been made available for issuance. The Company is currently evaluating the impact of the adoption of ASU 2017-09 on the Company’s financial statements.

In August 2017, FASB issued accounting standards update ASU-2017-12, “D” (Topic 815) – “Targeted Improvements to Accounting for Hedging Activities”, to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company is currently evaluating the impact of the adoption of ASU 2017-12 on the Company’s financial statements.

Management reviewed currently issued pronouncements ~~during the period ended September 30, 2017,~~ and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

~~ORIGINCLEAR, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS-UNAUDITED~~

~~SEPTEMBER 30, 2017~~

3.	CAPITAL STOCK

Preferred Stock

Series AC

~~On March 30, 2017, the Board of Directors of the Company authorized the withdrawal of the Series A preferred stock. As of September 30, 2017, no shares of Series A preferred stock were outstanding.~~

~~Series B~~

On October 1, 2015, the Company filed a Certificate of Designation for Series B preferred stock with the Secretary of State of Nevada and the shares of Series B preferred stock were issued to the shareholders of Progressive Water Treatment, Inc. in connection with the share exchange agreement. One third (1/3) of the shares received by the holder may be converted into common stock beginning one (1) year after the first date on which a share of Series B Preferred Stock was issued (the “Original Issue Date); one third (1/3) may be converted beginning two (2) years after the Original Issue Date; and the remaining one third (1/3) may be converted beginning three years after the Original Issue Date. The number of shares of common stock issuable for each share of converted Series B preferred stock shall be calculated by dividing the stated value by the market price, the market price shall be the average of the closing trade prices of the twenty-five (25) days prior to the date of the conversion notice. On August 12, 2016, the agreement was amended to include make-good-shares. The conversion price set forth in Section 1.2 of the agreement shall be adjusted to reflect the lower of $1.05 or the price of the Company’s common stock calculated using the average closing prices of the Company’s common stock on the last three (3) trading days prior to the date of conversion, provided, however, if the Average Closing Price is less than $0.35 per share, the adjusted conversion price shall be $0.35 per share. See Note 3. The conversion price is subject to adjustment in the case of reverse splits, stock dividends, reclassifications and the like. In addition, the conversion price is subject to certain full ratchet anti-dilution protection. Accordingly, the preferred stock is valued under the provision of ASC Topic 815, Derivatives and Hedging, because the conversion feature of the preferred stock was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The Series B preferred stock shall have the rights, preferences and privileges as set forth in the exchange agreement. As of September 30, 2017, there are 6,666 shares of Series B preferred stock outstanding.

~~Series C~~

On March 14, 2017, the Board of Directors authorized the issuance of 1,000 shares of Series C preferred stock, par value $0.0001 per share, to T. Riggs Eckelberry in exchange for his continued employment with the Company. The holder of Series C preferred stock is not entitled to receive dividends, is not entitled to any liquidation preference and shares of Series C preferred stock does not have any conversion rights. The Series C Preferred Stock entitles the holder to 51% of the total voting power of our stockholders. The purchase price of the Series C preferred stock was $0.0001 per share representing a total purchase price of $0.10 for 1,000 shares. As of September 30, 2022, there were 1,000 shares of Series C preferred stock outstanding held by Mr. Eckelberry.

~~Common Stock~~Series D-1

On April ~~7, 2017,~~13, 2018, the Company ~~filed~~designated 50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock. The shares of Series D-1 preferred stock are not entitled to dividends and do not have a ~~certificate~~liquidation preference. Each share of ~~amendment~~Series D-1 preferred stock is convertible into 0.0005 of one share of common stock. The Series D-1 preferred stock may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of our outstanding common stock, which amount may be increased to 9.99% at the holders discretion upon 61 days’ written notice. As of September 30, 2022, there were 31,500,000 shares of Series D-1 preferred stock issued and outstanding.

Series E

On August 14, 2018, the Company designated 4,000,000 shares of its ~~articles~~authorized preferred stock as Series E preferred stock. The shares of ~~incorporation~~Series E preferred stock are not entitled to dividends and not have a liquidation preference. Each share of Series E preferred stock is convertible into 0.05 shares of common stock. The shares of Series E preferred stock do not carry any voting rights. The Series E preferred stock may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of our outstanding common stock which amount may be increased to 9.99% at the holder’s discretion. During the nine months ended September 30, 2022, the Company issued an aggregate of 76,865 shares of common stock upon conversion of 1,537,213 shares of Series E preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of September 30, 2022, there were no shares of Series E preferred stock issued and outstanding.

Series F

On August 14, 2018, the Company designated 6,000 shares as Series F preferred stock. The shares of Series F preferred stock have a liquidation preference equal to the stated value of $1,000 per share plus any accrued but unpaid dividends. The Series F preferred stock is not convertible into common stock. The holders of outstanding shares of Series F preferred stock are entitled to quarterly dividends at the annual rate of 8% of the stated value, in preference to any dividends on the common stock. The shares of Series F preferred stock do not carry any voting rights. The Company may, in its sole discretion, at any time while the Series F preferred stock is outstanding, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value, plus any accrued but unpaid dividends. As of September 30, 2022, the Company had 60 outstanding shares of Series F preferred stock, which the Company was required to, and failed to redeem on September 1, 2020, and remains in default for an aggregate redemption price (equal to the stated value) of $60,000.

Series G

On January 16, 2019, the Company designated 6,000 shares as Series G preferred stock, each share having a stated value of $1,000 per share and holders of Series G preferred stock are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly. The Series G preferred stock does not have voting rights, except as required by law and is not convertible into common stock. The Company may, in its sole discretion, at any time while the Series G preferred stock is outstanding, redeem all or any portion of the outstanding Series G preferred stock at a price equal to the stated value plus any accrued but unpaid dividends. The Company was required to redeem such shares of Series G preferred stock on April 30, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. Pursuant to certain subscription agreements entered into with purchasers of the Series G preferred stock, each purchaser received shares of the Company’s common stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing price on the date the Company receives the executed subscription documents and purchase price from such investor. As of September 30, 2022, there were 25 shares of Series G preferred stock issued and outstanding, which the Company was required to, and failed to redeem on April 30, 2021, and was and remains in default for an aggregate redemption price (equal to the stated value) of $25,000.

Series I

On April 3, 2019, the Company designated 4,000 shares of preferred stock as Series I. The Series I has a stated value of $1,000 per share. Series I holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I is not entitled to any voting rights except as may be required by applicable law, and are not convertible into common stock. The Company has the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company was required to redeem such shares of Series I between May 2, 2021 and June 10, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. During the nine months ended September 30, 2022, the Company exchanged an aggregate of 210 shares of Series I preferred stock for 210 shares of Series W preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of September 30, 2022, there were 25 shares of Series I preferred stock issued and outstanding which the Company was required to, and failed to redeem by June 10, 2021, and was and remains in default for an aggregate redemption price (equal to the stated value) of $25,000.

Series J

On April 3, 2019, the Company designated 100,000 shares of preferred stock as Series J. The Series J has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the ~~State~~Company’s common stock. The Series J preferred stock is convertible into shares of ~~Nevada effectuating~~the Company’s common stock, on the terms and conditions set forth in the Series J COD, which includes certain make-good shares for certain prior investors. During the nine months ended September 30, 2022, the Company issued an aggregate of 512,737 shares of common stock upon conversion of 5 shares of Series J preferred stock, for a ~~reverse split~~loss in the amount of $5,203. As of September 30, 2022, there were 210 shares of Series J preferred stock issued and outstanding.

Series K

On June 3, 2019, the Company designated 4,000 shares of preferred stock as Series K. The Series K has a stated value of $1,000 per share. Series K holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series K is not entitled to any voting rights except as may be required by applicable law, and is not convertible into common stock. The Company has the right to redeem the Series K at any time while the Series K are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series K two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company was required to redeem such shares of Series K between August 5, 2021 and April 24, 2022, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. During the nine months ended September 30, 2022, the Company exchanged an aggregate of 85 shares of Series K preferred stock for 85 shares of Series W preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of September 30, 2022, there were 432 shares of Series K preferred stock issued and outstanding which the Company was required to, and failed to redeem by April 24, 2022, and was and remains in default for an aggregate redemption price (equal to the stated value) of $432,150.

Series L

On June 3, 2019, the Company designated 100,000 shares of preferred stock as Series L. The Series L has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series L preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series L COD, which includes certain make-good shares for certain prior investors. During the nine months ended September 30, 2022, the Company issued an aggregate of 25,145,849 shares of common stock upon conversion of 284 shares of Series L preferred stock, for a loss in the amount of $358,585. As of September 30, 2022, there were 321 shares of Series L preferred stock issued and outstanding.

Series M

On July 1, 2020, the Company designated 800,000 shares of its preferred stock as Series M. Each share of Series M has a stated value of $25. The Series M is not convertible into common stock. The holders of outstanding shares of Series M are entitled to receive dividends, at the annual rate of 10%, payable monthly, payable in preference and priority to any payment of any dividend on the common stock. The Series M is entitled to a liquidation preference in an amount equal to $25 per share plus any declared but unpaid dividends, before any payments to holders of common stock. The Series M have no pre-emptive or subscription rights, and there are no sinking fund provisions applicable to the Series M. The Series M does not have voting rights, except as required by law and with respect to certain protective provisions set forth in the Certificate of Designation of Series M preferred stock. To the extent it may lawfully do so, the Company may, in its sole discretion, at any time when there are outstanding shares of Series M, redeem any or all of the then outstanding shares of Series M at a redemption price of $37.50 per share (150% of the stated value) plus any accrued but unpaid dividends. As of September 30, 2022, there were 40,300 shares of Series M preferred stock issued and outstanding.

Series O

On April 27, 2020, the Company designated 2,000 shares of preferred stock as Series O. The Series O has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends (i) in cash at an annual rate of 8% of the stated value, and (ii) in shares of common stock of the Company (valued based on the conversion price as in effect on the last trading day of the applicable fiscal quarter) at an annual rate of 4% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series O has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series O has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series O. The Series O does not have voting rights except as required by law. The Series O is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series O being converted by the conversion price, provided that, the Series O may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series O at any time while the Series O are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. During the nine months ended September 30, 2022, the Company issued an aggregate of 1,258,812 shares of common stock upon conversion of 25 shares of Series O preferred stock and issued an aggregate of 917,821 shares of common stock in prorated 4% annualized dividends which were recorded as interest expense. The shares were issued within the terms of the agreement and no gain or loss was recognized. As of September 30, 2022, there were 590 shares of Series O preferred stock issued and outstanding.

Series P

On April 27, 2020, the Company designated 500 shares of preferred stock as Series P. The Series P has a stated value of $1,000 per share, and entitles holders to receive dividends on an as-converted basis with the Company’s common stock. The Series P is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Certificate of Designation of Series P preferred stock, which includes certain make-good shares for certain prior investors, and provided that, the Series P may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Series P entitles the holders to a payment on an as-converted and pari passu basis with the common stock upon any liquidation. The Series P has no preemptive or subscription rights, and there is no sinking fund or redemption provisions applicable to the Series P. The Series P votes on an as-converted basis with the common stock, subject to the beneficial ownership limitation. During the nine months ended September 30, 2022, the Company issued an aggregate of 3,527,317 shares of common stock upon conversion of 28 shares of Series P preferred stock, for a loss in the amount of $70,592. As of September 30, 2022, there were 30 shares of Series P preferred stock issued and outstanding.

Series Q

On August 21, 2020, the Company designated 2,000 shares of preferred stock as Series Q. The Series Q has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series Q has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series Q has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series Q. The Series Q does not have voting rights except as required by law. The Series Q is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series Q being converted by the conversion price, provided that, the Series Q may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series Q at any time while the Series Q are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense. During the nine months ended September 30, 2022, the Company issued an aggregate of 12,642,226 shares of common stock upon conversion of 100 shares of Series Q preferred stock and exchanged 200 shares of Series F preferred stock for 200 shares of Series Q preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of September 30, 2022, there were 615 shares of Series Q preferred stock issued and outstanding.

Series R

On November 16, 2020, the Company designated 5,000 shares of preferred stock as Series R. The Series R has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 10% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series R holders are not entitled to any voting rights except as may be required by applicable law. The Series R is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series R being converted by the conversion price; certain prior investors are also entitled to certain make-good shares; provided that, the Series R may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series R at any time while the Series R are outstanding at a redemption price equal to, if paid in cash, the stated value plus any accrued but unpaid cash dividends, or, if paid in shares of common stock, in an amount of shares determined by dividing the stated value being redeemed by the conversion price. The subscribers were offered warrants with the purchase of Series R but all warrants expired as of September 30, 2022. During the nine months ended September 30, 2022, the Company issued an aggregate of 44,494,096 shares of common stock upon conversion of 604 shares of Series R preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of September 30, 2022, there were 2,828 shares of Series R preferred stock issued and outstanding.

Series S

On February 5, 2021, the Company designated 430 shares of preferred stock as Series S. The Series S has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series S holders are not entitled to any voting rights except as may be required by applicable law. The Series S is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series S being converted by the conversion price, provided that, the Series S may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series S at any time while the Series S are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. As of September 30, 2022, there were 170 shares of Series S preferred stock issued and outstanding.

Series T

On February 24, 2021, the Company designated 630 shares of preferred stock as Series T. The Series T has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 10% of the stated value, payable monthly. The Series T holders are not entitled to any voting rights except as may be required by applicable law. The Series T is convertible into common stock of the Company pursuant to the Series T COD, provided that, the Series T may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company will have the right (but no obligation) to redeem the Series T at any time while the Series T are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. On March 1, 2021, the Company issued an aggregate of 630 shares of Series T Preferred Stock to an accredited investor (the “Purchaser’’) per terms of a Securities Purchase Agreement (the “SPA”). Per the SPA, the Company agreed to sell to Purchaser, and Purchaser agreed to purchase from the Company, 630 shares of the Company’s Series T, and two-year cashless warrants to acquire 25,200,000 shares of the Company’s common stock, valued at $0.05 per share per terms of the SPA, which may be exercised at any time in whole or in part. Per the SPA, the Series T, including any convertible shares acquired pursuant to exercise of the warrants, the Company shall pay 10% annual dividends in cash, paid monthly. Purchaser may convert any portion of the Series T, including convertible shares acquired pursuant to exercise of the warrants, at any time into shares of the Company’s common stock at an agreed upon conversion rate per terms of the SPA. The purchaser and the Company agreed that in lieu of the purchase price for the Series T, the Purchaser transferred to the Company real property, with an aggregate value agreed to be $630,000 based on an appraisal from an international independent company. The real property consists of residential real estate in Buenos Aires Argentina valued at $580,000, and eight undeveloped lots valued at $50,000 in Terralta private neighborhood development. The real property exchanged for 630 shares of Series T was recorded at $630,000 and reflected on the balance sheet as a ~~ratio~~long term asset for sale. The fair value of 1the warrants associated with acquiring 25,200,000 preferred shares were valued at $2,037,849, using the Black Scholes model and accounted for ~~35 (the “Reverse Split”)~~as deemed dividends and reflected in stockholder’s equity as accumulated paid in capital. The Company has actively listed the residential real property for sale since July 2021. On September 13, 2021, the Company received an offer for the property for $464,000, which was $116,000 below the original independent appraisal of $580,000. Based on that indicator of impairment, during the year ended December 31, 2021, the Company adjusted the original value of the long term asset for sale from $630,000 to $514,000 on the balance sheet and recorded an impairment of $116,000 in the consolidated financial statements. During the nine months ended September 30, 2022, the Company issued an aggregate of 83,105,450 shares of common stock upon conversion of 612 shares of Series T preferred stock. As of September 30, 2022, there were 18 shares of Series T preferred stock issued and outstanding.

Series U

On May 26, 2021, the Company designated 5,000 shares of preferred stock as Series U. The Series U has a stated value of $1,000 per share. The Series U holders are not entitled to any dividends and do not have any voting rights except as may be required by applicable law. The Series U is convertible into common stock of the Company in an amount determined by dividing 150% of the stated value of the Series U being converted by the conversion price; certain prior investors are also entitled to certain make-good shares; provided that, the Series U may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The ~~Reverse Split became effective~~conversion price is equal to the lesser of $0.20 or the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series U at any time at a redemption price equal to, if paid in cash, the stated value, or, if paid in shares of common stock, in an amount of shares determined by dividing 200% of the stated value being redeemed by the conversion price then in effect, and adding any applicable make-good shares. During the nine months ended September 30, 2022, the Company issued an aggregate of 30,629,247 shares of common stock upon conversion of 582 shares of Series U preferred stock. The shares were issued within the terms of the agreement and no gain or loss was recognized. As of September 30, 2022, there were 485 shares of Series U preferred stock issued and outstanding, along with 5,965,000 Series A warrants (with an exercise price of $0.10), 2,500,000 Series A1 warrants (with an exercise price of $0.10), 6,246,000 Series B warrants (with an exercise price of $0.25), and 1,561,500 Series C warrants (with an exercise price of $1.00) issued and outstanding with a fair value of $23,053 on the original issuance. The warrants were valued using the Black Scholes model (See Note 4).

Series W

On April 28, 2021, the Company designated 3,390 shares of preferred stock as Series W. The Series W has a stated value of $1,000 per share, and Series W holders are entitled to cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly. The Series W holders are not entitled to any voting rights except as may be required by applicable law. The Series W is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series W being converted by the conversion price; provided that, the Series W may not be converted into common stock to the extent such conversion would result in the ~~State~~holder beneficially owning more than 4.99% of ~~Nevada on April 12, 2017. Unless otherwise indicated, all share amounts, per share data, share prices, exercise prices,~~the Company’s outstanding common stock. The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series W at any time at a redemption price equal to the stated value plus any accrued but unpaid dividends. During the nine months ended September 30, 2022, the Company issued 85 shares of Series W preferred stock in exchange for 85 shares of Series K preferred stock, issued 210 shares of Series W preferred stock in exchange for 210 shares of Series I preferred stock and issued an aggregate of 21,489,284 shares of common stock upon conversion ~~rates set forth in this Quarterly Report~~of 245 shares of Series W preferred stock. The shares were issued within the terms of the agreement and ~~the accompanying unaudited condensed consolidated financial statement have, where applicable been adjusted retroactively to reflect this reverse~~no gain or loss was recognized. As of September 30, 2022, there were 795 shares of Series W preferred stock ~~split.~~issued and outstanding.

Series X

On ~~June 30, 2017,~~August 10, 2021, the Company ~~filed~~designated 25 shares of preferred stock as Series X. The Series X has a ~~certificate~~stated value of ~~amendment (the “Certificate of Amendment”)~~$10,000 per share. The Series X holders are not entitled to ~~amend Article 3 of its articles of incorporation with the State of Nevada, effectuating a decrease~~any dividends and do not have any voting rights except as may be required by applicable law. The Series X is convertible into common stock of the ~~number~~Company pursuant to the Series X COD, provided that, the Series X may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of ~~authorized~~the Company’s outstanding common stock (which amount may be increased up to 9.99% upon 61 days’ written notice). Beginning on the one year anniversary of the subscription agreement for the Series X Preferred Stock, until the two year anniversary of the subscription agreement, the holders will have the right to require the Company to redeem all of the Series X purchased by the subscriber at a price equal to 125% of the $250,000 original purchase price, or $312,500. The holders also have the right, exercisable at any time, to require the Company to redeem all of the holder’s Series X in exchange for the issuance of shares of the ~~Company. Pursuant~~Company’s common stock in an amount equal to 250% of the ~~Certificate~~original $250,000 purchase price, or $625,000, divided by the closing price of ~~Amendment,~~the Company’s common stock as of the date the holders executed the subscription agreement. On August 10, 2021, the Company ~~reduced the number~~issued and sold to an accredited investor an aggregate of ~~authorized~~25 shares of ~~its common~~Series X preferred stock ~~to 300,000,000. The Certificate~~for a purchase price of ~~Amendment became effective upon filing with~~$250,000. Per the ~~State~~Series X COD, as of ~~Nevada on June~~March 31, 2022, $140,000 of the $250,000 was classified as restricted cash. On August 10, 2022, holder of Series X removed that restriction. As of September 30, ~~2017. The reduction in the number of authorized shares does not affect the~~2022, there were 25 shares of ~~the Company’s~~Series X preferred stock issued and outstanding.

Series Y

On December 6, 2021, the Company designated 3,000 shares of preferred stock as Series Y. The Series Y has an original issue price of $100,000 per share, and holders are entitled to receive, on a pro rata and pari passu basis, annual distribution of up to 25% of annual net profits of newly established, wholly-owned, Water On Demand subsidiaries, designated by each holder, paid within 3 months of subsidiary’s accounting year-end. The Series Y holders are not entitled to any voting rights except as may be required by applicable law. The Series Y is convertible into common stock of the Company pursuant to the Series Y COD, provided that, the Series Y may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company has the right (but no obligation) to redeem the Series Y at any time at a redemption price equal to, if paid in cash, the original issue price plus any accrued but unpaid distributions of 25% of the subsidiary’s annual net profits. In addition, the Series Y holders are entitled to receive shares of Series A preferred stock in the Company’s subsidiary Water On Demand, Inc. Between January 20, 2022 and January 25, 2022, the Company issued 4 shares of Series Y preferred stock in exchange for 4 shares of Series V preferred stock for an aggregate value of $400,000, and issued an aggregate of 3,200,000 warrants with a fair value of $93,915 upon original issuance to the Series Y investors. During the nine months ended September 30, 2022, the Company issued an aggregate of 108,238,078 shares of common stock upon conversion of 15 shares of Series Y preferred stock. Per the Series Y COD, $2,604,639 of the $5,209,277 aggregate received for Series Y was classified as restricted cash. As of September 30, 2022, there were 37.1 shares of Series Y preferred stock along with 41,674,216 warrants with a fair value of $1,160,266 (with exercise prices between $0.13 and $0.25) issued and outstanding. The warrants were valued using the Black Scholes model (See Note 4).

Series Z

On February 11, 2022, the Company designated 25 shares of preferred stock as Series Z. The Series Z has an original issue price of $10,000 per share. The Series Z holders are not entitled to dividends or any voting rights except as may be required by applicable law. The Series Z is convertible into common stock of the Company pursuant to the Series Z COD, provided that, the Series Z may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which amount may be increased up to 9.99% upon 61 days’ written notice). The Company has the right (but no obligation) to redeem the Series Z at any time at a redemption price equal to the original issue price plus any accrued but unpaid distributions of 25% of Subsidiary’s annual net profits. On February 18, 2022, the Company issued and sold to an accredited investor an aggregate of 25 shares of Series Z preferred stock for a purchase price of $250,000 and issued an aggregate of 2,500,000 warrants with a fair value of $69,823 (with an exercise price of $0.10) to Series Z holders. As of September 30, 2022, there were 25 shares of Series Z preferred stock issued and outstanding.

As of September 30, 2022, the Company accrued aggregate dividends in the amount of $393,228 for all series of preferred stock.

The Series J, Series L, Series M, Series O, Series P, Series Q Series R, Series S, Series T, Series U, Series V, Series W, Series X, Series Y, and Series Z preferred stock are accounted for outside of permanent equity due to the terms of conversion at a market component or stated value of the preferred stock.

Common Stock

Nine months ended September 30, ~~2017~~2022

The Company issued ~~10,775,722 shares of common stock through private placements at prices of $0.05 to $0.175 per share for cash in the amount of $1,297,750.~~

~~The Company issued 9,321,555~~39,900,514 shares of common stock for the settlement of convertible promissory notes in an aggregate principal ~~in the~~ amount of ~~$485,000,~~$155,300, plus interest in the amount of ~~$107,145, with an~~$115,246, for a total aggregate ~~fair value loss on settlement~~ of ~~$732,826,~~$270,546 based upon a conversion ~~prices~~price of ~~$0.0651 to $0.2205.~~$0.00955.

The Company issued ~~886,700 shares of common stock for the settlement of accounts payable with a fair value of $90,000, with a fair value loss on settlement of $27,931.~~

~~The Company issued 35,734,233~~41,046,848 shares of common stock for services at fair value of ~~$3,418,598.~~$1,054,949, at share prices ranging from $0.0134 - $0.0438.

The Company issued 917,821 shares of common stock for Series O preferred stock dividends payable.

The Company issued 179,090,390 shares of common stock for settlement of conversion agreements at a fair value of $18,065.

The Company issued 331,043,096 shares of common stock upon conversion of 3,984,347 shares of preferred stock.

Nine Months Ended September 30, 2021

The Company issued 13,927,622 shares of common stock for the settlement of convertible promissory notes in an aggregate principal amount of $81,150, plus interest in the amount of $52,555, at a conversion price of $0.00955.

The Company issued 24,656,117 shares of common stock for services at fair value of $1,931,222, at share prices ranging from $0.0351 - $0.124.

The Company issued 495,366 shares of common stock for preferred Series O stock dividends payable.

The Company issued 119,049,835 shares of common stock upon conversion of 12,086 shares of preferred stock.

The Company issued 1,000,000 shares of common stock upon exercise of 1,000,000 warrants at an exercise price of $0.05 and received $50,000 from their exercise.

The Company issued 1,798,562 shares of common stock at a price of $0.0695 in conjunction with the sale of Series X preferred stock, and recognized a loss of $125,000 in the financial statements.

~~ORIGINCLEAR, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS-UNAUDITED~~

~~SEPTEMBER 30, 2017~~

4.	~~CONVERTIBLE PROMISSORY NOTES~~RESTRICTED STOCK AND WARRANTS

Restricted Stock to CEO

Between May 12, 2016, and January 1, 2022, the Company entered into Restricted Stock Grant Agreements (“the RSGAs”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the RSGAs are performance based shares. The RSGAs provides for the issuance of up to an aggregate of 242,109,214 shares of the Company’s common stock to Mr. Eckelberry provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 121,054,607 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported in the Company’s SEC Reports, the Company will issue up to an aggregate of 121,054,607 shares of its common stock. The Company has not recognized any costs associated with the milestones, because achievement is not probable. As the performance goals are achieved, the shares shall become eligible for vesting and issuance.

Restricted Stock to the Board, Employees and Consultants

Between May 12, 2016, and August 4, 2022, the Company entered into Restricted Stock Grant Agreements (“the BEC RSGAs”) with its members of the Board, employees, and consultants to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the BEC RSGAs are performance based shares. The BEC RSGAs provide for the issuance of up to 296,678,542 shares of the Company’s common stock to employees and consultants provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 148,339,271 shares of its common stock; b) If the Company’s consolidated operating profit Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC reports, the Company will issue up to an aggregate of 148,339,271 shares of its common stock. The Company has not recognized any costs associated with the milestones, because achievement is not probable. As the performance goals are achieved, the shares shall become eligible for vesting and issuance.

On August 14, 2019, the Board of Directors approved an amendment to the RSGAs and BEC RSGAs to include an alternative vesting schedule for the Grantees and on January 26, 2022, the Company amended the procedures for processing the RSGAs and BEC RSGAs. Once a Grantee is eligible to participate in alternate vesting, then they will be added to the list of alternate vestees, enlarging the pool of vestees among which, 10% of stock sales that are allowed under the agreement is divided for the next year. The Company then (i) calculates the value of the Company common stock traded in the year immediately prior to the vesting year, using daily adjusted close and volume, as quoted on the public securities trading market on which the Company’s common stock is then traded (ii) determines the cost basis of the shares, which shall be the closing price quoted on the public securities trading market, quoted on the first trading day of the vesting year which will be the grantee’s cost basis, and (iii) applies the 10% calculation and divides it into the number of qualifying alternate vestees, giving the gross number of shares available to each Grantee. For each alternate vestee for each year in which there occurs a vesting or a potential vesting, the Company (i) does a 90-day lookback from the first day of the latest vesting month, to limit cumulative vesting of shares for each alternate vestee for the 90-day period to 1% of total Company shares of common stock outstanding for the period, using the then current figure for shares outstanding at the time of the lookback; (ii) places the excess shares (the “Overlimit Shares”) in suspense for issuance in the next 90-day period so that in each future 90-day period they may be issued, and (iii) if on the 90-day lookback, cumulative issuances are less than 1% of shares outstanding, the Company will add the shares from previous 90-day lookback, if any. For the avoidance of doubt, the Company will not record any Overlimit Shares as vested until such as time as they have been finally issued. If the fair market value of the Company’s common stock on the date the shares are vested is less than the fair market value of the Company’s common stock on the effective date of the RSGA or BEC RSGA, then the number of vested shares issuable (assuming all conditions are satisfied) shall be increased so that the aggregate fair market value of vested shares issuable on the vesting date equals the aggregate fair market value that such number of shares would have had on the effective date. Upon the occurrence of a Company performance goal, the right to participate in the alternate vesting schedule will terminate, and the vesting of the remaining unvested shares will be as set forth under the restricted stock award agreement.

During the nine months ended September 30, 2022, upon qualifying under the alternative vesting schedule, the Company issued an aggregate of 632,327 shares relating to the RSGAs and an aggregate of 390,865 shares relating to the BEC RSGAs.

Warrants

During the nine months ended September 30, 2022, the Company granted 40,414,216 common stock purchase warrants, associated with the issuance of preferred stock. A summary of the Company’s warrant activity and related information follows for the nine months ended September 30, 2022:

	September 30, 2022
	Number of Warrants			Weighted average exercise price
Outstanding - beginning of period		217,085,783		$	0.0868
Granted		40,414,216		$	0.1234
Exercised		-			-
Expired/Exchanged		(162,526,010	)	$	0.0723
Outstanding - end of period		94,973,989		$	0.1201

At September 30, 2022, the weighted average remaining contractual life of warrants outstanding:

		September 30, 2022
						Weighted Average
						Remaining
Exercisable		Warrants		Warrants		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	0.02		600,000		600,000		3.92
$	0.05		25,200,000		25,200,000		0.42
$	0.10		10,965,000		10,965,000		0.21- 4.39
$	0.25		10,006,000		10,006,000		1.25 - 4.50
$	0.0275		8,727,273		8,727,273		8.66
$	0.125		37,914,216		37,914,216		4.22 - 4.99
$	1.00		1,561,500		1,561,500		1.75 - 2.21
			94,973,989		94,973,989

At September 30, 2022, the aggregate intrinsic value of the warrants outstanding was $0.

5.	CONVERTIBLE PROMISSORY NOTES

As of September 30, ~~2017,~~2022, the outstanding convertible promissory notes are summarized as follows:

Convertible Promissory Notes $ 3,667,068
Less debt discount 289,718
Convertible Promissory Notes, net of discount $ 3,377,350
Less current portion 296,722
Long term portion $ 3,080,628

Convertible Promissory Notes	$	2,926,755
Less current portion		878,283
Total long-term liabilities	$	2,048,472

~~At September 30, 2017,~~

Maturities of long-term debt for the ~~$3,667,068 in~~next three years are as follows:

Year Ending September 30,	Amount
2023		878,283
2024		2,034,700
2025		13,772
	$	2,926,755

On various dates from November 2014 through April 2015, the Company issued unsecured convertible promissory notes ~~has a remaining debt discount of $289,718, leaving a net balance of $3,377,350.~~

~~On various dates, the Company entered into unsecured convertible notes~~ (the ~~“Convertible Promissory~~“2014-2015 Notes” ~~or “Notes”~~), that matured ~~during the period~~on various dates and were extended for an additional sixty (60) ~~days~~months from the effective date of each Note. The 2014-2015 Notes bear interest at 10% per ~~annum.~~year. The maturity dates were extended to November 2023 through April 2024. The 2014-2015 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of ~~$2.10~~$4,200 to ~~$4.90~~$9,800 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2014-2015 Notes. In addition, for as long as the 2014-2015 Notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the 2014-2015 Notes or such other convertible notes or a term was not similarly provided to the purchaser of the 2014-2015 Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the 2014-2015 Notes and such other convertible notes. The conversion feature of the 2014-2015 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2014-2015 Notes. During the nine months ended September 30, ~~2017,~~2022, the Company issued ~~9,321,555~~39,900,514 shares of common stock, upon conversion of ~~$395,000~~$153,300 in principal, plus accrued interest of ~~$107,145, with a fair value loss on settlement of $732,826.~~$115,247. As of September 30, ~~2017,~~2022, the 2014-2015 Notes had an aggregate remaining balance of ~~$1,560,000.~~$774,700, which are short term.

~~As of September 30, 2017,~~

The unsecured convertible promissory notes (the “OID Notes”) had an aggregate remaining ~~principal~~ balance of $184,124, plus accrued interest of ~~$13,334 were amended.~~$13,334. The OID Notes included an original issue discount and ~~one time~~one-time interest, which has been fully amortized. The OID Notes matured on December 31, 2017, which were extended ~~through December 31, 2017.~~to June 30, 2023. The OID Notes were convertible into shares of the Company’s common stock at a conversion price initially of ~~$15.31.~~$30,620. After the amendment, the conversion price changed to the lesser of ~~$2.80~~$5,600 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date. The conversion feature of the ~~notes~~OID Notes was considered a derivative in accordance with current accounting guidelines, because of the reset conversion features of the ~~notes.~~OID Notes. As of September 30, 2022, the remaining balance on the OID Notes was $62,275, which is long term.

The Company ~~entered into~~issued various, unsecured convertible promissory notes (the ~~“Notes”~~“2015 Notes”), on various dates ~~ending on May 19, 2016.~~with the last of the 2015 Notes being issued in August 2015. The 2015 Notes matured and were extended from the date of each tranche through maturity dates ending on ~~May 19, 2020.~~February 2024 through March 2024, and April 2024 through August 2024. The 2015 Notes bear interest at 10% per ~~annum.~~year. The 2015 Notes ~~may be converted~~are convertible into shares of the Company’s common stock at conversion prices ranging from the lesser of ~~$0.70~~$1,400 to ~~$2.80~~$5,600 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015 Notes. The conversion feature of the 2015 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2015 Notes. ~~The~~As of September 30, 2022, the 2015 Notes had an aggregate remaining balance of ~~the note as~~$1,200,000, of ~~September 30, 2017, was $1,325,000. The Company recorded amortization of debt discount,~~ which ~~was recognized as interest expense in the amount of $11,479 during the nine months ended September 30, 2017.~~ $1,200,000 is long term.

~~ORIGINCLEAR, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS-UNAUDITED~~

~~SEPTEMBER 30, 2017~~

4.	~~CONVERTIBLE PROMISSORY NOTES (Continued)~~

The Company issued a convertible note (the “Dec 2015 Note”) in exchange for an accounts payable in the amount of $432,048, which could be converted into shares of the Company’s common stock after December 31, 2015. The ~~note~~Dec 2015 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The ~~note~~Dec 2015 Note did not meet the criteria of a derivative, and was accounted for as a beneficial conversion feature, which was amortized over the life of the ~~note~~Dec 2015 Note and recognized as interest expense in the financial statements. On January 1, 2016, the ~~note~~Dec 2015 Note met the criteria of a derivative and was accounted for under ASC 815. The ~~note~~Dec 2015 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. As of ~~December 31, 2016,~~September 30, 2022, the remaining balance on the Dec 2015 Note was $257,048. During the nine months ended September 30, 2017, the Company issued 886,700 shares of common stock upon conversion of principal in the amount of $90,000, with a fair value loss on settlement of $27,931. As of September 30, 2017, the Note had a remaining balance of $167,048. The Company recorded amortization of debt discount,$167,048, which ~~was recognized as interest expense in the amount of $161,574 during the nine months ended September 30, 2017.~~is short term.

The Company issued a convertible note (the “Sep 2016 Note”) in exchange for an accounts payable in the amount of $430,896, which could be converted into shares of the Company’s common stock after September 15, 2016. The ~~note~~Sep 2016 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. ~~On September 15,~~The Sep 2016 ~~the note~~Note met the criteria of a derivative and was accounted for under ASC 815. The ~~note~~Sep 2016 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. The ~~note~~Sep 2016 Note did not meet the criteria of a derivative at the ~~time it was entered into,~~date of the issuance, and was accounted for as a beneficial conversion feature, which was amortized over the life of the ~~note~~Sep 2016 Note and recognized as interest expense in the financial statements. The conversion feature of the Sep 2016 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion feature of the Sep 2016 Note. As of September 30, 2022, the remaining balance on the Sep 2016 Note was $430,896, which is short term.

The Company issued two (2) unsecured convertible promissory notes (the “Apr & May 2018 Notes”), in the aggregate amount of $300,000 on April 2, 2018 and May 31, 2018. The Apr & May 2018 Notes had maturity dates of April 2, 2019 and May 31, 2019, respectively. The Apr & May 2018 Notes bear interest at 10% per year. The Apr & May 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty-five (25) trading days prior to conversion. The conversion feature of the Apr & May 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. On March 13, 2019, the Company entered into a settlement agreement with the investor in the amount of $570,000, based on the outstanding balance due and payable under the Apr & May 2018 Notes. The Company set up a reserve of 2,630,769 shares of common stock of the Company for issuance upon conversion by the investor of the amounts owed under the Notes, in accordance with the terms of the Notes, including, but not limited to the beneficial ownership limitations contained in the Notes. In addition to the foregoing, upon the sale by the investor of the settlement shares as delivered to the investor by the Company, resulting in total net proceeds less than the settlement value, the investor is entitled to additional settlement shares of the Company’s common stock. If after the investor has sold all settlement shares, the investor delivers a written notice to the Company certifying that the investor is entitled to additional settlement shares of the Company’s common stock (the “Make-Whole Shares”). The number of make-whole shares being equal to the greater of ((i) zero and (ii) the quotient of (1) the difference of (x) the settlement value with respect to each sale of shares by the Investor after the delivery of the Settlement Shares, minus (y) the aggregate net consideration received by the Investor from the resale of all shares of common stock issued by the Company, divided by (2) the average trailing closing price for ten (10) trading days for the shares immediately preceding the date of delivery of the make-whole shares. As of September 30, 2022, the remaining balance on the May 2018 Note was $218,064, which is short term.

The Company entered into an unsecured convertible promissory note (the “Nov 20 Note”), on November 19, 2020 in the amount of $50,000. The Company received funds in the amount of $50,000. The Nov 20 Note had an original maturity date of November 19, 2021 and was extended for an additional sixty (60) months from the maturity date. The Nov 20 Note bears interest at 10% per year. The Nov 20 Note may be converted into shares of the Company’s common stock at a lesser price of $0.05 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Nov 20 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. As of September 30, 2022, the remaining balance on the Nov 20 Note was $13,772, which is long term.

The Company entered into an unsecured convertible promissory note (the “Jan 21 Note”), on January 25, 2021 in the amount of $60,000. The Company received funds in the amount of $60,000. The Jan 21 Note had an original maturity date of January 25, 2022 and was extended for an additional sixty (60) months from the maturity date. The Jan 21 Note bears interest at 10% per year. The Jan 21 Note may be converted into shares of the Company’s common stock at a conversion price equal to the lower of (a) $0.05 per share, (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Jan 25 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of ~~$140,543~~$3,743 during the nine months ended September 30, ~~2017.~~2022. As of September 30, 2022, the balance of the Jan 21 Note was $60,000, which is long term.

We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory notes was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable, so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically according to the stock price fluctuations.

The derivative liability recognized in the financial statements as of September 30, ~~2017~~2022 was ~~$10,728,464.~~$35,702,830.

5.6.	~~OPTIONS AND WARRANTS~~REVENUE FROM CONTRACTS WITH CUSTOMERS

~~Options~~Equipment Contracts

~~On May 25, 2012, the Board of Directors adopted a new OriginOil, Inc. 2012 Incentive Stock Option Plan (the “2012 Plan”) for the purposes of granting stock options to its employees~~

Revenues and others providing services to the Company, which reserves and sets aside for the granting of options for 28,571 shares of common stock. Options granted under these plans may be either incentive options or nonqualified options and shall be administered by the Company’s Board of Directors. Each option shall be exercisable to the nearest whole share, in installments or otherwise,related costs on equipment contracts are recognized as the respective option agreements may provide. Notwithstanding any other provision of the 2012 Plan or of any option agreement, each option shall expire on the date specified in the option agreement, which date shall not be later than the tenth (10th) anniversary from the effective date of grant.

~~On June 14, 2013, the Board of Directors adopted a new OriginOil, Inc. 2013 Incentive Stock Option Plan (the “2013 Plan”)~~performance obligations for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for 114,286 shares of common stock. Options granted under the Plan may be either incentive options or nonqualified options and shall be administered by the Company’s Board of Directors. Each option shall state the number of shares to which it pertains. The exercise price will be determined by the holders’ percentage owned as follows: If the holder owns more than 10% of the total combined voting power or value of all classes of stock of the Company, then the exercise price will be no less than 110% of the fair market value of the stock as of the date of grant; if the person is not a 10% holder, then the exercise price will be no less than 100% of the fair market value of the stock as of the date of grant. Notwithstanding any other provision of the 2013 Plan or of any option agreement, each option shall expire on the date specified in the option agreement, which date shall not be later than the tenth (10th) anniversary from the date of grant. If the status of an employee terminates for any reason other than disability or death, then the optionee or their representative shall have the right to exercise the portion of any options which were exercisable as of the date of such termination, in whole or in part, not less than 30 days nor more than three (3) months after such termination.

~~ORIGINCLEAR, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS-UNAUDITED~~

~~SEPTEMBER 30, 2017~~

5.	~~OPTIONS AND WARRANTS (Continued)~~

On September 29, 2015, the Board of Directors adopted a new OriginClear, Inc. 2015 Equity Incentive Stock Option Plan (the “2015 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for 3,315,714 shares of common stock. On October 2, 2015, the Board of Directors amended the number of shares to reserve for issuance to 4,571,429 shares. Options granted under these plans may be either incentive options or nonqualified options and shall be administered by the Company’s Board of Directors. Each option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective option agreements may provide. Notwithstanding any other provision of the 2015 Plan or of any option agreement, each option shall expire on the date specified in the option agreement, which date shall not be later than the fifth (5th) anniversary from the effective date of grant.

During the year ended December 31, 2016, the Company granted 31,429 shares of incentive stock options to employees, and 428,571 shares of non-statutory options to consultants. Each option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective option agreements may provide. The stock options mature on March 29, 2021 and October 17, 2021, at prices of $0.29 and $1.31.

With respect to Non-Statutory Options granted to employees, directors or consultants, the Board of Directors or Committee of the Board of Directors may specify such period for exercise that the option shall automatically terminate following the termination of employment or services as to shares covered by the option as the Board of Directors or Committee of the Board of Directors deems reasonable and appropriate.

~~A summary of the Company’s stock option activity and related information follows:~~

September 30, 2017
Weighted
Number of average exercise
Options price
Outstanding, beginning of period 3,697,495 $ 1.505
Granted - -
Exercised - -
Forfeited/Expired - -
Outstanding, end of period 3,697,495 $ 1.505
Exercisable at the end of the period 2,682,644 $ 1.035
Weighted average fair value of options granted during the period $ -

~~The weighted average remaining contractual life of options outstanding issued under the 2009 Plan, 2012 Plan, and 2013 Plan as of September 30, 2017 was as follows:~~

Weighted Average
Stock Stock Remaining
Exercisable Options Options Contractual
Prices Outstanding Exercisable Life (years)
$ 6.65 - 147.00 52,276 50,401 4.84 - 7.02
$ 10.15 - 15.40 32,362 32,362 5.96
$ 1.31 3,612,857 2,599,881 3.22 - 4.05
3,697,495 2,682,644

Stock-based compensation expense recognized during the year is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. Stock-based compensation expense recognized in the financial statements of operations during the nine months ended September 30, 2017 and 2016 were $71,603 and $155,112, respectively.

~~As of September 30, 2017, there was no intrinsic value with regards to the outstanding options.~~

~~ORIGINCLEAR, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS-UNAUDITED~~

~~SEPTEMBER 30, 2017~~

5.	~~OPTIONS AND WARRANTS (Continued)~~

~~Restricted Stock to CEO~~

On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the RSGAwork are performance based shares and none have yet vested nor have any been issued. The RSGA provides for the issuance of up to 1,714,286 shares of the Company’s common stock to the Employees provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculatedsatisfied over time in accordance with ~~generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for~~Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit will be recognized as the ~~trailing twelve month period as reported~~customer obtains control of the goods and services promised in the ~~Company’s quarterly or annual financial statements,~~contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will ~~issue up to 857,143 shares~~recognize the loss as it is determined.

The following table represents a disaggregation of ~~its common stock; b) If the Company’s consolidated operating profit (~~~~Operating Profit = Operating Revenue - Cost~~revenue by type of ~~Goods Sold - Operating Expenses - Depreciation & Amortization),~~~~calculated in accordance~~good or service from contracts with ~~generally accepted accounting principles, equals or exceeds $1,500,000~~customers for the ~~trailing twelve month period~~September 30, 2022 and 2021.

	Nine Months Ended
	September 30,
	2022		2021
Equipment Contracts	$	5,829,960	$	1,662,869
Component Sales		1,390,243		841,203
Waste Water Treatment Systems		325,005		57,729
Pump Stations		179,005		182,591
Rental Income		19,719		21,260
Services Sales		24,201		82,635
	$	7,768,133	$	2,848,287

Revenue recognition for other sales arrangements, such as ~~reported as reported~~sales for components, and service sales will remain materially consistent.

Contract assets represents revenues recognized in excess of amounts billed on contracts in progress. Contract liabilities represents billings in excess of revenues recognized on contracts in progress. Assets and liabilities related to long-term contracts are included in current assets and current liabilities in the ~~Company’s SEC Reports,~~accompanying balance sheets, as they will be liquidated in the Company will issue up to 857,143 shares of its common stock. The Company has not recognized any costs associated with the milestones, due to not being able to estimate the probability of it being achieved. As the performance goals are achieved, the shares shall become eligible for vesting and issuance.

On August 10, 2016, the Company entered into a Restricted Stock Grant Agreement (the “August RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performancenormal course of the ~~Company and to increase its value and stock price. All shares issuable under the August RSGA are performance based shares and none have yet vested nor have any been issued.~~contract completion. The August RSGA provides for the issuance of up to 1,714,286 shares of the Company’s common stock to the CEO provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 857,143 shares of its common stock; b) If the Company’s consolidated operating profit (~~Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization),~~calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to 857,143 shares of its common stock. The Company has not recognized any costs associated with the milestones, due to not being able to estimate the probability of it being achieved. As the performance goals are achieved, the shares shall become eligible for vesting and issuance.

~~Restricted Stock to Employees and Consultants~~

On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “First Employee RSGA”) with an employee, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the First Employee RSGA are performance based shares and none have yet vested nor have any been issued. The First Employee RSGA provides for the issuance of up to 857,143 shares of the Company’s common stock to the employee provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to 428,571 shares of its common stock; b) If the Company’s consolidated operating profit (~~Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization),~~calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to 428,571 shares of its common stock. The Company has not recognized any costs associated with the milestones, due to not being able to estimate the probability of it being achieved. As the performance goals are achieved, the shares shall become eligible for vesting and issuance.

On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “Second Employee RSGA”) with an employee, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Second Employee RSGA are performance based shares and none have yet vested nor have any been issued. The Second Employee RSGA provides for the issuance of up to 571,429 shares of the Company’s common stock to the employee provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to 285,714 shares of its common stock; b) If the Company’s consolidated operating profit (~~Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization),~~calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to 285,714 shares of its common stock. The Company has not recognized any costs associated with the milestones, due to not being able to estimate the probability of it being achieved. As the performance goals are achieved, the shares shall become eligible for vesting and issuance.

~~ORIGINCLEAR, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS-UNAUDITED~~

~~SEPTEMBER 30, 2017~~

5.	~~OPTIONS AND WARRANTS (Continued)~~

~~Restricted Stock to Employees and Consultants~~ ~~(Continued)~~

On August 10, 2016, the Company entered into a Restricted Stock Grant Agreement (the “Consultants RSGA”) with two of its’ consultants, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Consultants RSGA are performance based shares and none have yet vested nor have any been issued. The Consultants RSGA provides to each of the consultants the issuance of up to 285,714 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to each of the consultants up to 142,857 shares of its common stock; b) If the Company’s consolidated operating profit (~~Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization),~~calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to 142,857 shares to each of the consultants, its common stock. The Company has not recognized any costs associated with the milestones, due to not being able to estimate the probability of it being achieved. As the performance goals are achieved, the shares shall become eligible for vesting and issuance.

~~Warrants~~

During the nine months ended September 30, 2017, the Company issued 22,825,000 purchase warrants to prospective investors in connection with a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended, Rule 506 promulgated under Regulation D of the Securities Act and Regulation S of the Securities Act. A summary of the Company’s warrant activity and related information followscontract asset for the nine months ended September 30, ~~2017:~~2022 and the year ended December 31, 2021, was $1,455,464 and $378,932, respectively. The contract liability for the nine months ended September 30, 2022, and the year ended December 31, 2021, was $692,570 and $1,886,946, respectively.

7.	FINANCIAL ASSETS

Fair value investment in Securities

September 30, 2017
Weighted
Number average
of exercise
Warrants price
Outstanding-beginning of the period 506,026 $ 5.25
Granted 22,825,000 $ 0.02
Exercised - -
Forfeited (27,296 ) $ (22.37 )
Outstanding - end of the period 23,303,730 $ 0.13

AtOn November 12, 2021, the Company served a conversion notice to WTII and recorded additional interest and fees of $15,988 through that date, according to the terms of the securities purchase agreement for an aggregate of $149,867. The Note was converted into 45,208,649 shares of WTII common stock. As of September 30, ~~2017,~~2022, the ~~weighted average remaining contractual life~~investment in securities was recorded at fair value in the amount of ~~warrants outstanding:~~$45,209, with an unrealized loss of $153,709.

Weighted
Average
Remaining
Exercisable Warrants Warrants Contractual
Prices Outstanding Exercisable Life (years)
$ 5.25 - 22.75 461,537 461,537 0.24 - 0.70
$ 0.35 - 0.12 22,825,000 22,825,000 0.67 – 1.17
$ 31.50 2,858 2,858 5.13
$ 8.75 - 22.75 14,335 14,335 0.05 – 0.97
23,303,730 23,303,730

AtOn May 15, 2018, the Company received 4,000 shares of Water Technologies International, Inc. (“WTII”) Series C convertible preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. Each share of Series C convertible preferred stock is convertible into one thousand (1,000) shares of WTII common stock. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality was delivered immediately, the revenue was recognized in the financial statements as of June 30, 2018. As of September 30, ~~2017,~~2022, the ~~aggregate intrinsic~~fair value of the ~~warrants outstanding~~preferred shares was ~~$253,930.~~$6,000.

6.8.	~~FOREIGN SUBSIDIARY~~LOANS PAYABLE

OnSecured Loans Payable

The Company entered into short term loans with various lenders for capital expansion secured by the Company’s assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. As of December 31, ~~2014,~~2020, the finance cost was fully amortized. During the year ended December 31, 2021, the Company ~~formed~~settled the majority of the loans in the amount of $262,250, of which $157,250 was recognized on the statement of operations as a ~~wholly owned subsidiary, OriginClear (HK)~~gain on write-off of loan payable. The term of the loans ranged from two months to six months. During the period ended September 30, 2022, the Company ~~Ltd (OCHK),~~received $25,000 as a settlement and wrote off $50,000 of secured loans payable. The net balance as of September 30, 2022 was $30,646.

Small Business Administration Loans

Between April 30, 2020 and September 12, 2020, the Company received total loan proceeds in ~~Hong Kong, China.~~the amount of $505,000, which included an aggregate of $345,000 under the Paycheck Protection Program (the “PPP”) under the Coronavirus Aid, Relief and Economic Security Act, an Economic Injury Disaster Loan (the “EIDL”) in the amount of $150,000, and an Economic Injury Disaster Grant in the amount of $10,000. The principal and accrued interest under the PPP was forgivable if the Company used the PPP loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and otherwise complied with PPP requirements. The Company ~~has granted OCHK~~used the full proceeds of the PPP loan specifically for eligible purposes per requirements of the PPP and during the period ending December 31, 2021, the Company submitted satisfactory documentation regarding its compliance with the applicable requirements and obtained forgiveness of the PPP loan. The Company must repay any unforgiven principal amount, with interest, on a ~~master license~~monthly basis following the deferral period for the ~~People’s Republic~~EIDL. For the period ended December 31, 2021, the aggregate amount of ~~China,~~$345,000 received under the PPP, and ~~a non-exclusive license for~~ the ~~rest~~Economic Injury Disaster Grant in the amount of ~~Asia. In turn, OCHK is expected~~$10,000 was recognized in the statement of operations as other income due to ~~license regional joint ventures for the commercial development of EWS:AOx Technology. A research and manufacturing center are also planned.~~forgiveness.

The Company entered into a ~~month-to-month~~capital lease ~~agreement~~for the purchase of equipment during the year ended December 31, 2018. The lease is for a sixty (60) month term, with monthly payments of $757 per month, and a purchase option at the end of the lease for $1.00. As of September 30, 2022, there remain a current balance of $1,169.

On January 22, 2020 the Company entered into a strategic partnership with Permionics Separations Solutions, Inc., a unit of India’s Permionics Group (“Permionics”) for the Asia-Pacific Region. This strategic partnership assists the Company with overcoming the typical hurdles in commercializing a technology overseas with engineering support, developing customer proposals, infrastructure to handle logistics and purchasing, inventory and shipping from and into foreign countries, customer training, startup assistance and service.

The Company believes that Permionics is best suited to accomplish all of the above for its customers in the Asia-Pacific countries and as a result, has terminated all activities of its fully owned subsidiary, OriginClear Technologies Limited, in Hong Kong, China, working instead with Permionics when applicable.

The Company acquired real estate assets to be held for sale to finance their water projects, by issuing 630 shares of Series T preferred stock for a fair value of $630,000, in conjunction with common stock purchase warrants, through an asset purchase agreement. The assets held for sale consisted of residential property, plus eight (8) lots of undeveloped land. The real property has been listed actively on the market to be sold. Based on the offers received and the market conditions, the Company adjusted the fair value by $116,000 leaving a fair value of $514,000.

Our Dallas based subsidiary, PWT, rents an approximately 12,000 square foot facility located at 2535 E. University Drive, McKinney, TX 75069, with a ~~shareholder of the Company for office space in McKinney, Texas at a base~~current monthly rent of ~~$4,750 per month.~~$7,900.

Generally, a PWT project is guaranteed against defects in material and workmanship for one year from the date of completion, while certain areas of construction and materials may have guarantees extending beyond one year. The Company has various insurance policies relating to the guarantee of completed work, which in the opinion of management will adequately cover any potential claims. A warranty reserve has been provided under PWT based on the opinion of management and based on Company history in the amount of $20,000 ~~as of~~for the nine months ended September 30, ~~2017.~~2022.

There are no material updates to the litigation matters with C6 Capital, LLC nor Auctus Fund, LLC as previously disclosed in the Form 10-Q filed on August 15, 2022.

Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has determined that there are the following subsequent events:

OnBetween October ~~3, 2017, a holder~~7, 2022 and October 28, 2022, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of ~~Series B Preferred Stock converted 3,333~~1.8 shares of the Company’s Series ~~B Preferred Stock into~~Y preferred stock for an aggregate purchase price of $177,000. The Company also issued an aggregate of ~~1,428,429~~1,416,000 warrants to these investors.

Between October 18, 2022 and November 2, 2022, the Company issued to consultants an aggregate of 7,067,670 shares of the Company’s common ~~stock. The~~stock for services.

On October 19, 2022, OriginClear, Inc. (the “Company”) entered into an Equity Financing Agreement (“Financing Agreement”) with GHS Investments, LLC (“GHS”), whereby GHS agreed to purchase, through puts made from time to time by the Company, up to $25,000,000 worth of the shares (“Shares”) of the Company’s common stock, ~~issued included 476,143 shares issued upon conversion~~par value $0.0001 per share. In accordance with the terms of the ~~3,333 shares of Series B Preferred Stock at $1.05 per share~~Financing Agreement and ~~952,286 shares as a one-time make good issuance as per~~ the ~~Certificate of Designation of Series B Preferred Stock and agreement~~Registration Rights Agreement dated October 20, 2022 between the Company and GHS (“Registration Agreement”), the ~~holder.~~Company is required to register the Shares on Form S-1 with the Securities and Exchange Commission (“SEC”) as a condition precedent to GHS’s obligation to close on the purchase of the Shares.

~~As previously reported, the Company has commenced an offering under Regulation 506c of Regulation D (the “Private Placement”)~~On October 20, 2022, holders of the Securities Act of 1933, as amended (the “Securities Act”) pursuant to which the Company shall sell units of its securities (the “Units”) with each Unit consisting of (i) one restricted share of its commonCompany’s Series Y preferred stock (ii) a Class A Warrant to purchase one share of its common stock, (iii) a Class B Warrant to purchase one share of its common stock, (iv) a Class C Warrant to purchase one share of its common stock and (v) a Class D Warrant to purchase one share of its common stock to qualified investors. Between October 12, 2017 and November 13, 2017, the Company sold, in the Private Placement,converted an aggregate of ~~11,100,000~~3 Series Y shares ~~of its common stock to accredited investors for an aggregate consideration of $277,500.~~

~~On October 20, 2017, holders of convertible promissory notes converted an aggregate principal and interest amount of $31,410~~ into an aggregate of ~~2,052,968~~20,204,082 shares, including make-good shares, of the Company’s common stock.

~~In connection with certain one-time make good agreements, between~~On October ~~2, 2017 and October 31, 2017,~~25, 2022, holders of the ~~Company issued~~Company’s Series U preferred stock converted an aggregate of ~~1,342,185~~100 Series U shares into an aggregate of ~~its common stock to certain holders of its common stock.~~

On November 10, 2017, the Company entered into a Restricted Stock Grant Agreement (the “RSGA”) with Jean Louis Kindler, the Company’s Chief Commercial Officer and Director, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. The RSGA provides for the issuance of up to 2,000,0005,868,545 shares of the Company’s common ~~stock provided certain milestones are met in certain stages. All shares issuable under the RSGA are performance based shares and none have yet vested nor have any been issued.~~

~~Between October 31, 2017 and~~On November ~~13, 2017,~~3, 2022, holders of the ~~Company issued to consultants~~Company’s Series T preferred stock converted an aggregate of ~~5,680,648~~18 Series T shares into an aggregate of 3,176,471 shares of the Company’s common ~~stock in lieu of cash consideration.~~ stock.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

~~Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.~~

This Quarterly Report on Form 10-Q contains forward-looking statements that are subject to a number of risks and uncertainties, many of which are beyond our control, which may include statements about our:

All statements, other than statements of historical fact included in this report, regarding our strategy, intellectual property, future operations, financial position, estimated revenues and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. When used in this report, the words “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. All forward-looking statements speak only as of the date of this report. You should not place undue reliance on these forward-looking statements. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this report are reasonable, we can give no assurance that these plans, intentions or expectations will be achieved. These statements may be found under “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” as well as in this report generally. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact ~~occur~~ occur.

OriginClear, Inc. (“we”, “us”, “our”, the “Company” or “OriginClear”) was incorporated on June 1, 2007 under the laws of the State of Nevada. We have been engaged in business operations since June 2007. ~~We are currently commercializing~~In 2015, we moved into the commercialization phase of our ~~technology through joint ventures~~business plan having previously been primarily involved in research, development and licensing ~~while operating a water treatment service company in Texas, which we have designated a certified manufacturer for our technology.~~activities. Our principal offices are located at ~~525 S. Hewitt St., Los Angeles, California 90013.~~13575 58th Street North, Suite 200, Clearwater, FL 33760. Our main telephone number is ~~(323) 939-6645.~~(727) 440-4603. Our website address is www.OriginClear.com. ~~In addition~~The information contained on, connected to ~~announcing material financial information through~~or that can be accessed via our ~~investor relations~~ website ~~press releases, SEC filings and webcasts, we also intend to use the following social media channels as a means~~is not part of disclosing information about our products, our planned financial and other announcements, our attendance at upcoming investor and industry conferences, and other matters and for complying with our disclosure obligations under Regulation FD:this report.

OriginClear is a company that today, develops unique water assets for eventual launch as their own companies. This new role was indicated water technology company which has developed in-depth capabilities over the eight years since it began to operate in the water industry.

Pursuant to this new mission, OriginClear’s assets, subsidiaries and product offerings consist of:

As they are subject to a security guaranty by the Company, the WOD Subsidiaries, and the capital raised for them through the Company’s Series Y offering, shall continue to be held by the Company. This capital will be made available to WODI to be deployed, subject to a planned management contract.

The Company develops and incubates businesses in its role as the Clean Water Innovation Hub™ (“CWIB”). The mission of CWIB in general, is to create valuable properties through an incubation process that results in the launching of valuable spinoffs that add value to the world’s water industry.

The first such spinoff was on April 13, 2022, when the Company’s Board of Directors approved the plan to spin off its Water On Demand business into a newly formed wholly-owned subsidiary, Water On Demand Inc., which will hold the assets, liabilities, intellectual property and business operations of the Water On Demand business.

Further businesses can be expected to be spun off, as the Company announced on April 26, 2022:

“The launch of Water on Demand is the first of several anticipated business property spinoffs. Other Company business properties include Modular Water Systems, which owns a master license to five key international patents for prefabricated, highly-durable modular water treatment and pumping products. Being a proprietary technology, MWS frequently qualifies as “Basis of Design” for projects, which means that competitors cannot easily undercut MWS.”

(https://www.originclear.com/company-news/originclear-to-launch-water-on-demand-fintech-startup)

~~The information we post through these social media channels~~On July 8, 2022, the Company announced that it booked combined purchase orders in excess of $5 million in the first nine months of 2022, more than double the order volume for the comparable period in 2021.

On September 21, 2022, the Company announced its collaboration with PhilanthroInvestors™ to develop off-grid housing solutions. PhilanthroInvestors™ promotes human welfare while earning a financial return.

https://www.originclear.com/company-news/originclear-teams-up-with-real-estate-leader-for-off-grid-housing

On October 18, 2022, the Company announced that its pump station product line is showing commercial success. Known as EveraMOD in the Modular Water Systems (MWS) lineup, this durable, modular system is being adopted by customers, often as a simple yet vital retrofit for existing, obsolete installations.

In addition, the Company indicated that it may ~~be deemed material. Accordingly, investors should monitor these accounts,~~spin off EveraMOD as its next independent company as part of CWIB.

https://www.originclear.com/company-news/originclears-pump-station-line-rapidly-expands

On October 25, 2022, the Company announced that it entered an Equity Financing Agreement with GHS Investments (GHS). Pursuant to the Agreement, GHS has agreed to purchase up to $25.0 million in ~~addition to following~~registered common stock, with timing and amounts of the ~~company’s press releases, SEC filings, public conference calls and webcasts. This list may be updated from time to time.~~

~~We have not incorporated by reference into thisreport the information in, or that can be accessed through, our website or social media channels, and you shouldnot consider it~~purchases to be determined at the sole discretion of the Company.

On November 7, 2022, the Company announced that it retained The Basile Law Firm, P.C. (www.thebasilelawfirm.com), to explore a ~~part of this report.~~potential business combination with a NASDAQ-listed Special Purpose Acquisition Corporation (SPAC). OriginClear cautions that a specific SPAC has not been definitively identified, the prospective terms are unknown, and there is no assurance any transaction may occur.

~~OriginClear is~~Dallas-based Progressive Water Treatment Inc. (“PWT”), a ~~leading~~designer, builder and service provider ~~of water treatment solutions and the developer of a breakthrough water cleanup technology. Through its wholly owned subsidiaries, OriginClear provides systems and services to treat water in~~for a wide range of ~~industries,~~industrial water treatment applications. PWT, together with MWS, other proprietary technologies and potential future acquisitions, aims to offer a complementary, end-to-end offering to serve growing corporate demand for outsourced water treatment.

Since 1995, PWT has been designing and manufacturing a complete line of water treatment systems for municipal, industrial and pure water applications. PWT designs and manufactures a complete line of water treatment systems for municipal, industrial and pure water applications. Its uniqueness is its ability to gain an in-depth understanding of customer’s needs and then to design and build an integrated water treatment system using multiple technologies to provide a complete solution for its customers.

PWT utilizes a wide range of technologies, including chemical injection, media filters, membrane, ion exchange and SCADA (supervisory control and data acquisition) technology in turnkey systems. PWT also offers a broad range of services including maintenance contracts, retrofits and replacement assistance. In addition, PWT rents equipment in contracts of varying duration. Customers are primarily served in the United States and Canada, with the company’s reach extending worldwide from Siberia to Argentina to the Middle East.

In the first quarter of 2019, the Company increased the number of the manufacturer’s representatives for its operating units, PWT and Modular Water Systems (“MWS”).

On Nov 7, 2019, the Company published a case study showing how its Modular Water System may help automotive dealerships expand into rural land. The case study shows how point-of-use treatment solves lack of access to the public sewer system.

On March 5, 2020, the Company announced disruptive pump and lift station pricing, stating that its prefabricated modules with a lifespan of up to 100 years now compete with precast concrete.

On April 15, 2021, the Company announced that its Progressive Water Treatment division is now shipping BroncBoost™, its workhorse Booster Pump Station equipment line. Engineered and built in Texas, BroncBoost allows customers to control water flow rates and pressure for mission critical water distribution systems.

On August 25, 2021, PWT entered into a Master Services Agreement (MSA) with a large US public utility company for water filtration systems that will provide process water at three power plants. The utility issued a purchase order for approximately $1.8 million, for the first power plant. The total purchase price payable to PWT under the MSA is approximately $5 million, subject to certain conditions, including receipt and acceptance by PWT of additional purchase orders. We expect the overall contract to take up to two years to deliver from the date of the MSA.

On June 22, 2018, OriginClear signed an exclusive worldwide licensing agreement with Daniel “Dan” Early P. E. for his proprietary technology for prefabricated water transport and treatment systems. On July 19, 2018, the Company began incubating its Modular Water Treatment Division (MWS) around Mr. Early’s technology and perspective customers. The Company has funded the development of this division with internal cash flow. In Q1 of 2020, the Company fully integrated MWS with wholly-owned Progressive Water Treatment Inc. The Company is currently developing MWS as a discrete line of business for an eventual spinoff. Mr. Early currently serves as Chief Engineer for OriginClear.

On July 19, 2018, the Company launched its Modular Water Treatment Division, offering a unique product line of prefabricated water transport and treatment systems. Daniel “Dan” Early P.E. (Professional Engineer) heads the Modular Water Systems (“MWS”) division. On June 25, 2018, Dan Early granted the Company a worldwide, exclusive non-transferable license to the technology and knowhow behind MWS (See “Intellectual Property”). A ten-year renewal on May 20, 2020 added the right to sublicense and create manufacturing joint ventures. On July 25, 2018, MWS received its first order, for a brewery wastewater treatment plant.

With PWT and other companies as fabricators and assemblers, MWS designs, manufactures and delivers prefabricated water transport (pump and lift stations) under the EveraMOD™ brand; and wastewater treatment plant (“WWTP”) products under the EveraSKID™ and EveraTREAT™ brands to customers and end-users which are required to clean their own wastewater, such as ~~municipal, pharmaceutical, semiconductors,~~schools, small communities, institutional facilities, real estate developments, factories, and industrial parks.

On September 28, 2021, the Company announced that MWS deployed its pilot Pondster™ brand modular lagoon treatment system at a Mobile Home Park (MHP) or trailer park, in Troy, Alabama.

On June 16, 2022 the Company announced that MWS received purchase orders for approximately $1.5 Million in May of 2022. This compared to $1,774,880 in purchase orders for the entire year 2021.

On July 25, 2022 the Company announced that decentralized water treatment, long pioneered by OriginClear’s Modular Water Systems™ (MWS), is now being mandated by major US cities to recycle water in large new buildings.

On August 12, 2022 the Company announced the inaugural delivery and ~~oil & gas. To rapidly grow this segment~~installation of its pre-engineered EveraBOX™ to implement a low-risk Liquid Ammonium Sulfate (LAS) disinfectant system for Pennsylvania’s Beaver Falls Municipal Water Authority (BFMA). Typical of MWS products, EveraBOX is manufactured using inexpensive, long-lasting High-Density Polyethylene (HDPE) or Polypropylene (PP) materials. These materials have proven to be less affected by supply chain issues currently impacting metal and fiberglass construction.

OriginClear is also developing a new outsourced water treatment business called “Water On Demand”: or “WOD” as a potential revenue source. The WOD model intends to offer private businesses the ability to pay for water treatment and purification services on a per-gallon basis. This is commonly known as Design-Build-Own-Operate or “DBOO”. On April 13, 2021, we announced formation of a wholly-owned subsidiary called Water On Demand #1, Inc. (“WOD #1”) to pursue capitalization of the ~~business, we strategically acquire profitable~~equipment required. The WOD Subsidiaries, Water On Demand #2, Inc. (“WOD #2”), Water On Demand #3, Inc. (“WOD #3”), Water On Demand #4, Inc. (“WOD #4”) were separately created to permit optional segmenting of capital pools according to strategic partnerships. The Company is now simplifying this structure by placing all funds in WOD #1 and ~~well-managed~~tracking the partnerships within that company. As they are subject to a security guaranty by the Company, the WOD Subsidiaries, and the capital raised for them through the Company’s Series Y offering, shall continue to be held by the Company. This capital will be made available to WODI to be deployed, subject to a planned management contract.

The Company intends to pilot a first DBOO contract and thereafter, work with regional water service companies to build and operate the water treatment systems it finances. Additional financing hubs could be set up in world financial centers.

Delegating the building and operating of WOD-financed systems to regional water companies under performance contract, with the aim of developing a network of such partners, is expected to enable rapid scale-up of the WOD program, and the partner network would create a high barrier to entry for competitors.

On April 13, 2022, the Company’s Board of Directors approved the plan to spin off its Water On Demand business into a newly formed wholly-owned subsidiary, Water On Demand Inc., which will hold the assets, liabilities, intellectual property and business operations of the Water On Demand business.

The Company stipulates that it has excluded the WOD Subsidiaries, and all capital already raised and to be raised in the future in its Series Y offering, from this assignment of assets and will make the capital available as part of a planned management contract. The Company intends to also register a Regulation A offering by WODI which is intended to accumulate capital for WODI to direct toward WOD projects.

To enable rapid scaling, WODI does not initially intend to build, maintain or service the water treatment systems it finances, but instead contract with regional water service companies to carry out these functions. On April 6, 2022, an agreement in principle was reached to work with the first of these intended contractors, Envirogen Technologies (www.envirogen.com), a 30-year international provider of environmental technology and process solutions (www.originclear.com/company-news/originclear-and-envirogen-to-partner-on-water-on-demand). Future resources to build, maintain and service these financed systems may come from acquisitions; however, these are not actively being planned.

At the time of this filing, WODI had no staff or independent resources. Under a prospective management services contract, OCLN is providing all staffing and administrative resources, as well as access to the funds it has raised for WOD investments.

On a global basis, only twenty percent (20%) of all sewage and thirty percent (30%) of all industrial waste are ever treated. Water leakage results in the loss of thirty-five percent (35%) of all clean water across the planet. Cutting that number in half would provide clean water for 100 million people. This is a situation of great danger, but also great potential.

We believe businesses can no longer rely on giant, centralized water utilities to meet the challenge. That is why more and more business users are doing their own water treatment and recycling. Whether by choice or necessity, those businesses that invest in onsite water systems gain a tangible asset on their business and real estate and can enjoy better water quality at a lower cost, especially if treated water is recycled.

We believe self-reliant businesses are quietly building “decentralized water wealth” for themselves while also helping their communities. Environmental, social and governance (ESG) investing guidelines, which drive about a quarter of all professionally managed assets around the world, specifically include the key factor of how well corporations manage water.

As civil infrastructure ages and fails and as the costs for new and replacement infrastructure increase year over year, we believe engineers and end-users will search for new ways and methods of deploying water and wastewater systems that are less expensive to deliver and much less expensive to own and operate with the mission intent of substantially increasing the replacement intervals currently experienced by conventional materials of construction and conventional product delivery models.

Inflation of water rates greatly exceeds core inflation (see Figure 2), creating a risk for managers of businesses served by municipalities. We believe this creates an incentive for self-treatment; but these businesses may lack the capital for large water plant expenditures, and the in-house expertise to manage them. Outsourcing through what we call Water on Demand™ means that these companies do not have to worry about the problem, either financing it or managing it.

As an example, in information technology, few companies operate their own server in-house powering their website. Rather, such servers are typically managed by professionals through a service level agreement. In the water industry, when applied to outsourced water treatment, a service level agreement is known as O&M agreement. When the vendor retains ownership of the equipment, the concept is expanded to “Own and Operate”, an extension of the basic “Design and Build”, for a full offering known as DBOO, which is very similar to the solar energy programs known as Power Purchase Agreements (“PPAs”).

Under such a plan, a business can outsource its wastewater treatment by simply signing on the dotted line; instantly avoiding most capital expense, and the trouble of managing something that is a distraction from their core business.

We believe this is financially and operationally attractive to industrial, agricultural and commercial water users, while OriginClear’s Water On Demand program can potentially drive speeded-up deals and more revenue streams from providing water treatment as a service.

An updated report of October 2018, “Public Spending on Transportation and Water Infrastructure, 1956 to 2017” (www.cbo.gov/system/files?file=2018-10/54539-Infrastructure.pdf), stated that The Federal Government’s and State and Local Governments’ Spending on Water Utilities, including water supply and wastewater treatment facilities, was $4 billion in 2016 – a drop of about $13 billion since 1976!

As municipalities continue to be underfunded (Figure 1) with rising water rates (Figure 2), businesses are increasingly choosing to treat and purify their own water, in a trend known as Decentralized Water, first described in the Lux Research presentation of June 28, 2016. (https://members.luxresearchinc.com/research/report/20060).

According to the Lux Research data, the unmet infrastructure needs of America’s 150,000+ water systems will exceed $100 billion per year by 2025. And the recent Infrastructure Investment and Jobs Act only provided one-time funding of $55 billion, which is less than one year’s deficit.

It is this underfunding that is creating the water quality problems we are seeing in places like Flint, Michigan and Jackson, Mississippi.

It is not realistic to expect this underfunding of central water to be resolved anytime soon. The alternative is to simply reduce the load on these central systems. Since industry and agriculture together account for 89% of all water demand in the United States (https://ourworldindata.org/water-use-stress), we can enable commercial users to purify their own wastewater, thereby enabling water districts to focus on serving residential users – achieving a major social justice victory by simply unburdening the central facilities.

Self-treatment is a win-win, too – because businesses can do better by treating their own water; for instance, implementing recycling of the water they pay for, and controlling their own costs.

But to make such a decentralization program work, capital is needed. Most businesses simply do not have it in their capital plan to treat their own water. Now, with Water On Demand, they can forget about investing in capital and expertise: they can simply continue to pay on the meter as they always have, but to a micro-utility that sits on their own premises.

In 2018, OriginClear launched its Modular Water Systems (MWS) division (www.modularwater.com), headed by Daniel M. Early, P.E., a pioneer of on-site or decentralized water treatment in this country. Supported by its proprietary technology, this division already serves businesses doing their own water treatment. These modular systems can be easily put to work for pre-funded, pay-per-gallon applications, potentially creating a barrier to entry for other companies wanting to do the same.

Also, the portable nature of some of these prefabricated, drop-in-place Modular Water Systems may provide a competitive benefit for a pure service model where the equipment remains the property of the Company, because their mobility enables some degree of repossession in the event the client fails to pay their monthly bill. We believe this is a key competitive advantage.

Finally, we could license MWS technology to Water On Demand operating partners under contract to design, build and operate systems, thus achieving both acceptance of such technology and a standardized “fleet” of installed systems.

On March 17, 2021, OriginClear incorporated Water On Demand #1 Inc. (“WOD#1”) in Nevada as a wholly owned subsidiary to operate and manage our Water on Demand business.

In November 2021, the Company created additional Water on Demand subsidiaries – Water on Demand # 2, Inc. (WOD # 2), Water on Demand # 3, Inc. (WOD # 3) and Water on Demand # 4, Inc. (WOD # 4) were separately created to permit optional segmenting of capital pools according to strategic partnerships. The Company is now simplifying this structure by placing all funds in WOD #1 and tracking the partnerships within that company. As they are subject to a security guaranty by the Company, the WOD Subsidiaries, and the capital raised for them through the Company’s Series Y offering, shall continue to be held by the Company. This capital will be made available to WODI to be deployed, subject to a planned management contract.

The Company requires funding in order to execute on its Water on Demand initiative. As of the period ended September 30, 2022, the Company received aggregate funding in the amount of $2,604,639 through the sale of its Series Y Preferred Stock dedicated to the Water on Demand program.

The Company is now actively evaluating potential clients for a test of water treatment and purification services on a pay-per-gallon basis, but a first agreement has not been reached. Also, the Company, as represented by OCLN, is in early stage talks with partners to deliver DBOO services, with the Company providing financing and contract management services. In the event such talks do not succeed, the Company, represented under contract by OCLN, would need to implement its own resources for such DBOO services.

On April 6, 2022, the Company agreed in principle to an arrangement with Houston-based, international water service company Envirogen Technologies for certain operations and maintenance (O&M) functions, the first of a potential series of such partnerships, intended to enable Water On Demand to focus on finance and asset management while the water industry benefits from a steady stream of pre-capitalized projects.

(https://www.originclear.com/company-news/originclear-and-envirogen-to-partner-on-water-on-demand)

On April 13, 2022, the Company announced the formation of Water On Demand, Inc. (“WODI”) as a wholly owned subsidiary and its plans to transfer each of the WOD subsidiaries and all assets, intellectual property and operations related to the Water On Demand business to WODI. The Company now stipulates that it has excluded the WOD Subsidiaries, and all capital already raised and to be raised in the future in its Series Y offering, from this assignment of assets and will make the capital available as part of a planned management contract. The Company intends to also register a Regulation A offering by WODI which is intended to accumulate capital for WODI to direct toward WOD projects.

On June 29, 2022 the Company announced the launch of its $300 Million offering (the “Reg D Offering”) to be conducted on behalf of its wholly-owned subsidiary, Water on Demand, Inc. (“WODI”). The offering of the securities is made pursuant to an exemption from registration under Rule 506(c) of Regulation D, to accredited investors only. Water On Demand is designed to offer clean water systems to businesses and communities as a managed service without any capital requirement. Due to a planned separate filing of a Regulation A+ Offering (the “Reg A Offering”), the Company has decided to limit the Reg D Offering to $20 million in total.

In September 2020, OriginClear announced that Philanthroinvestors had entered a strategic agreement with the Company and had listed the Company on its new Water Philanthroinvestors program. At the same time, the Company appointed Philanthroinvestors Founder, Ivan Anz and CEO, Arte Maren to OriginClear’s Board of Advisors.

On May 10, 2021, OriginClear filed “System And Method For Water Treatment Incentive”, a patent application for using blockchain technology and non-fungible tokens (“NFT”) to simplify the distribution of payments on outsourced water treatment and purification services billed on a pay-per-gallon basis ahead of inflation, or Water On Demand. The Company recently filed a PCT application pertaining to the invention.

On May 16, 2021, the Company applied for a registered trademark for the mark $H2O (also referred to as H2O) as the blockchain system representing this activity. The current filing basis is “Intent-to-use basis” (under Trademark Act Section 1(b)).

On June 10, 2021, the Company named Ricardo Fabiani Garcia, key OriginClear investor and a veteran technologist, to the Company’s Board of Advisors. Mr. Garcia is helping to plan the eventual rollout of $H2O.

There is no active development effort for $H2O. Depending on the final form that $H2O takes, we may encounter regulatory concerns that we cannot guarantee we will overcome. In that event, we would fall back on ordinary financial payment systems. Neither our Water on Demand or other current business models rely on any blockchain system for operation, and we can accomplish our operational goals using ordinary financial and currency channels. The Company does not intend to incorporate a blockchain system in any registered offering.

OriginClear is currently exploring a utility coin, or token, named ClearAqua, The Water Coin For The World™, which would implement a grassroots network for alerts, leading to actionable proposals for water projects. There is no assurance this token will be issued or if issued, will be successful. ClearAqua is not required for OriginClear’s core business.

We filed, on an intent-to-use basis, US Trademark applications on July 21, 2021, for the Mark, CLEARAQUA. We also engaged San Diego-based Baja Technologies Inc. (“Baja”) who wrote a preliminary white paper, but no other action has been taken and ClearAqua is not in active development at this time. The Company does not intend to incorporate a coin, token or cryptocurrency in any registered offering.

The Company, in its role as the CWIB, seeks to incubate or acquire businesses that help industrial water users achieve water self-sustainability. We believe that assembling a group of such water treatment and water management businesses is potentially an opportunity for spinoffs and increased Company value for the stockholders.

We are particularly interested in companies which allow us to expand our global market presence and technical expertise. To enable a new era of clean and socially responsible water treatment solutions, we invented Electro Water Separation™, a breakthrough high-speed water cleanup technology using multi-stage electrochemistry, which we license worldwide to water treatment equipment manufacturers. Water is our most valuable resource and the mission of The OriginClear Group™ (the “Group”) is to improve the quality of water and help return it to its original and clear condition.

~~Outsourcing is a fast-growing reality in water treatment. Tougher~~successfully execute on Design-Build-Own-Operate or DBOO. These companies are growing fast, because tougher regulations, water scarcities and general outsourcing trends are driving industrial and agricultural water treatment users to delegate their water problem to service providers. As Global Water Intelligence pointed out in their report on October 30, 2015, ~~“Water~~“Water is often perceived as a secondary importance, with end-users increasingly wanting to focus solely on their own core business. This is driving a move away from internal water personnel towards external service experts to take control of water aspects.” External service experts are typically ~~small,~~ small–privately owned and locally operated. ~~Consolidating these companies~~Creating a network of such providers could lead to enormous economies of scale through sharing of best practices, technologies, and ~~customers. Decentralization is~~customers and could represent a major barrier to entry for Water On Demand’s competitors.

The Company cautions that suitable acquisition candidates may not be identified and even if identified, the Company may not have adequate capital to complete the acquisition and/or definitive agreement may not be reached. Internally-incubated businesses, similarly, may not become commercial successes.

On June 25, 2018, Dan Early granted the Company a worldwide, exclusive non-transferable license to intellectual property consisting of five issued US patents, and design software, CAD, marketing, design and specification documents (“Early IP”).

On May 20, 2020, we agreed on a renewal of the license for an ~~even greater trend in water, similar~~additional ten years, with three-year extensions. We also gained the right to ~~what has been seen in energy decentralization through solar~~sublicense, and, wind off-grid generation. Water is becoming increasingly scarcer. McKinsey’s Transforming Water Economies forecasts that “without action, global water demand could outstrip supply by upwith approval, to ~~40 percent by 2030.” Furthermore, existing water infrastructure in~~create ISO-compliant manufacturing joint ventures.

The Early IP consists of combined protection on the ~~United States is aging~~materials and ~~water loss is increasing. According to Lux Research, updating the country’s national water infrastructure will require an investment~~configurations of $270 billion; money that will be hard to pull together for projects that could take decades to complete. In the meantime, centralized water systems are forcing water users to treat their own water with small, modular water treatment systems. OriginClear is acquiring companies to help industrial water users treat their water themselves, and often reuse it. We believe those companies are going to grow tremendously because of this “local water” growth trend. We believe that assembling a group of water treatment companies is an opportunity for significant growth and increased Company value for the stockholders.

On October 1, 2015, Dallas-based Progressive Water Treatment, Inc. (“PWT”) became the first company in the Group. PWT is a fast-growing designer, builder and service provider for a wide range of industrial water treatment applications. PWT reported revenue of $4,794,637 for the period ending December 31, 2016. For the first nine months of 2017, PWT reported revenue of $2,215,491 which is included in the consolidated financial statements ending September 30, 2017.

~~Since 1995, PWT has been designing and manufacturing a~~ complete ~~line of~~packaged water treatment systems, ~~for municipal, industrial and pure water applications. Known as an OEM (Original Equipment Manufacturer), PWT utilizes a wide range~~built into containers. The patents consist of technologies, including chemical injection, media filters, membrane, ion exchange and SCADA technology, in turnkey systems that it designs and builds. PWT also offers a broad range of services including maintenance contracts, retrofits and replacement assistance. In addition, PWT rents equipment through contracts of varying duration. Customers are primarily served in the ~~United States and Canada, with PWT’s reach extending worldwide from Japan to Argentina to the Middle East.~~following:

~~OriginClear is currently in discussions for additional, accretive acquisitions of companies specializing in complementary markets and applications.~~

For its first eight years of operations, OriginClear focused uniquely on development and commercialization of its breakthrough Electro Water Separation™ technology. In 2015, the technology went into commercial phase, and the Company launched it as OriginClear Technologies, operating in parallel to the Group. The mission of OriginClear Technologies is to develop Electro Water Separation™ and achieve its full recognition as an international industry standard in treating our increasingly complex wastewater treatment challenges. For this purpose, OriginClear Technologies relies on an ongoing strong R&D and engineering activity for the development of its technology, while actively building its network of partners, licensees and joint venture partners for commercial development. A key element of this strategy is OriginClear (HK), OriginClear’s wholly-owned subsidiary in Hong Kong that manages Asia-Pacific market development, with a special focus on China sales and manufacturing. While OriginClear Technologies focuses on developing and monetizing the Company’s internally-developed Intellectual Property, best practices and trade secrets, it is expected to do the same for technologies which may result in future from the Group’s acquisition of profitable water treatment companies.

OriginClear is the proprietary developer of Electro Water Separation™ (EWS), the high-speed, primarily chemical-free technology to clean up large quantities of water. It removes oils, suspended solids, certain dissolved solids, and pathogens, in a continuous and energy-efficient process. The Company originally developed this technology to solve the challenge of removing microalgae from a highly dilute state. The EWS technology remains the most efficient non-chemical, continuous mechanism for the concentration of live algae cells from water. The electro-chemical process was then extended, first to cleaning up oil and gas waste water and most recently, to industrial, agricultural and urban effluents. These water treatment applications are entirely electrochemical in nature and do not rely on algae for its cleaning capabilities, which is a separate application of the technology. EWS is designed to be an early step in removal of oils, solids and pathogens; reducing the work that more expensive, downstream processes such as Ultra Filtration or Reverse Osmosis must do, therefore enabling more cost-efficient and high-volume water cleanup overall.

~~In March of 2016,~~On May 10, 2021, OriginClear announced that it had ~~successfully developed~~filed “System And Method For Water Treatment Incentive”, a patent application for using blockchain technology and ~~proved Advanced Oxidation~~non-fungible tokens (NFT) to simplify the distribution of payments on outsourced water treatment and purification services billed on a pay-per-gallon basis ahead of inflation.

With the rising need for ~~its breakthrough~~local, point-of-use or point-of-discharge water cleanup system, EWS. University laboratory tests have shown that EWS with Advanced Oxidation (EWS:AOx™) can now extract dissolved contaminants, which are otherwise difficult to remove without chemicals such as chlorine. Overall,treatment solutions, the system has shown a dramatic reduction in Total Organic Compounds which includes all forms of organic contamination, solids, miscible or dissolved, to meet new stringent global discharge requirements. Even prior to this innovation, EWS, combined with an iSep ultrafiltration membrane, demonstrated upModular Water Systems licensed IP family is the core to a 99.9% removal of dispersed oil, 99.5% removal of suspended solids as well as successful treatment of chemical oxygen demand (COD), including specific contaminants such as ammonia, phosphorus and hydrogen sulfide. These results were presented at the International Water Conference in 2015. In 2016, OriginClear filed for a patent, which is still pending, to protect the new AOx process andportable, integrated, transportable, plug-and-play system ~~configuration.~~

~~Today, we are capable of pairing the two technologies as EWS:AOx™, or separately, as the application requires. OriginClear believes~~ that, its technology is valuable to the industry because it has the potential to greatly extend the life of membranes and filters by effectively treating very dirty, oily water, while reducing chemical use significantly. OriginClear also believes that its Advanced Oxidation technology will help neutralize harmful micro-contaminants, such as industrial solvents, which is difficult or impossible to achieve withunlike other technologies. Overall, the system has shown a dramatic reduction in Total Organic Compounds which includes all forms of organic contamination, solids, miscible or dissolved, to meet new stringent global discharge requirements.

~~Recently, with our initial commercial contract for a landfill upgrade in Malaysia, we have shown that our systems~~packaged solutions, can be ~~retrofitted into existing installations, avoiding~~manufactured in series, have a longer life and are more respectful of the ~~time and expense of ground-up construction and enabling rapid compliance with new, stringent discharge regulations for treatment companies.~~environment.

The common feature of this IP family is the use of a construction material (Structural Reinforced ThermoPlastic), for the containers that is:

In addition, patents US 8,372,274 and US 8,871,089 (1 and 3) relate to the use of vessels or containers made out of this material combined with a configuration of functional modules, or process, for general water treatment.

Other subsequent patents, which build upon the original claims, focus on more targeted applications. These patents outline a given combination of modules engineered inside the vessel to address a specific water treatment challenge.

In April 2019, we completed the expansion of our manufacturer’s representative network to serve both PWT and MWS for customer lead generation.

~~Nearly two-thirds of the human body~~Beginning with its first installation, PWT built MWS components. The Company is water. And that water (entering our bodies directly, or indirectly through food), is increasingly contaminated with a potent mix of chemicals, such as glyphosate or Roundup, atrazine, dioxane, estrogen, pharmaceutical drugs and much, much more. These chemicals are directly implicated in many disorders including cancer. Their effect may be greatly increasedcurrently developing MWS as a ~~cocktail~~discrete line of ~~chemicals,~~business for an eventual spinoff, and MWS systems are built and assembled by a network of fabrication partners. In addition, the ~~destructiveness of which we can only guess at. Bottled water~~Company is ~~often contaminated, too. In fact, it is very difficult to find truly pure water, whether in~~developing the ~~water we drink, or in the water that irrigates our crops.~~EveraMOD Pump Station product line as a standalone business.

In the water treatment industry, Advanced Oxidation Process (AOP) is employed to create abundant reactive oxygen species (ROS), which kill all organic material, even many of the micro-toxins that are otherwise so difficult to remove. OriginClear believes it has invented the next generation of AOP, using electrical reaction efficiently, and capable of being applied to drinking water in a variety of settings including, ultimately, the home. Our breakthrough process, for which we filed our latest patent in March of 2016, is called AOx. We used this process in July of 2017 to demonstrate in the laboratory the ability to virtually eliminate the herbicide glyphosate from drinking water by up to 99.3%, according to independent test results.

~~We believe that AOx can be a simpler and effective way to treat water for many micro-toxins at city treatment plants, at irrigation districts, in bottling water plants and eventually in the home.~~

~~We are continuing to test for various contaminants, and to invent ways to effect the removal of microtoxins, real-time and in a number of settings.~~

~~Meanwhile, we are pursuing research alliances. And in the future, we plan to work with licensing and joint venture partners to take the technology to market.~~

The Securities and Exchange Commission (“SEC”) defines “critical accounting policies” as those that require application of management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Not all of the accounting policies require management to make difficult, subjective or complex judgments or estimates. However, the following policies could be deemed to be critical within the SEC definition.

We recognize revenue ~~upon delivery~~when services are performed, and at the time of ~~equipment,~~shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Title to the equipment is transferred to the customer once the last payment is received. We record revenue as goods are shipped, and the equipment has been fully accepted by the customer. Generally, we extend credit to our customers and do not require collateral. We do not ship a product until we have a purchase agreement signed by the customer with a payment arrangement.

Revenues and related costs on construction contracts are recognized ~~using~~as the ~~“percentage of completion method” of accounting~~performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC ~~605-35 – “~~~~Accounting for Performance of Construction-Type~~606, revenue and ~~Certain Production Type Contracts”.~~~~Under this method, contract revenues and related expenses are~~associated profit, will be recognized ~~over~~as the ~~performance period~~customer obtains control of the goods and services promised in the contract in direct proportion to the costs incurred as a percentage of total estimated costs for the entirety of the contract. Costs include direct material, direct labor, subcontract labor and any allocable indirect costs.(i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss, as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined.

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts ~~reported in~~of assets and liabilities, disclosure of contingent assets and liabilities at the ~~accompanying financial statements. Significant estimates made in preparing these~~date of the financial statements, ~~include the estimate of useful lives of property and equipment, the deferred tax valuation allowance,~~ and the ~~fair value~~reported amounts of ~~stock options, warrants, convertible notes~~revenues and ~~common stock for services.~~expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s goodwill, impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, inventory valuation, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Fair value of financial instruments requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of ~~Nine months,~~September 30, 2022, the amounts reported for cash, prepaid expenses, accounts payable and accrued expenses approximate the fair value because of their short maturities.

Results of Operations for the three months ended September 30, ~~2017~~2022 compared to the three months ended September 30, ~~2016.~~ 2021.

For the three months ended September 30, ~~2017,~~2022, we had revenue of ~~$1,112,438~~$3,366,061 compared to ~~$1,019,919~~$1,120,687 for the three months ended September 30, ~~2016.~~2021. Cost of sales for the three months ended September 30, ~~2017,~~2022 was ~~$949,657~~$2,542,887 compared to ~~$574,105~~$790,336 for the three months ended September 30, ~~2016.~~2021. Revenue and cost of sales increased primarily due to ~~PWT’s focus on operations.~~our subsidiary’s increase in revenue.

Our gross profit was ~~$162,781~~$823,174 and ~~$445,814~~$330,351 for the three months ended September 30, ~~2017~~2022 and ~~2016,~~2021, respectively.

For the three months ended September 30, ~~2017,~~2022, we had selling and marketing expenses of ~~$539,975,~~$712,420, compared to ~~$303,496~~$636,481 for the three months ended September 30, ~~2016. Selling~~2021. The increase in selling and marketing expenses ~~increased~~was primarily due to an increase in ~~investor relations and~~ marketing expense.

~~General~~For the three months ended September 30, 2022, we had general and administrative expenses ~~increased~~of $1,085,044 compared to ~~$830,444,~~$1,006,041 for the three months ended September 30, ~~2017, compared~~2021. The increase in general and administrative expenses was primarily due to ~~$629,455~~an increase in professional and legal fees and outside services.

Other income and (expenses) increased by $47,787,918 to $(28,067,729) for the three months ended September 30, ~~2016. General and administrative expenses increased primarily due~~2022, compared to ~~an increase in professional fees and outside services.~~

~~Research and development cost~~$19,720,189 for the three months ended September 30, ~~2017 and 2016, were $53,939 and $106,259, respectively. The decrease in research and development costs was primarily due to a decrease in outside services and other research and development costs.~~

~~Depreciation expense for the three months ended September 30, 2017 and 2016 was $12,961 and $11,331, respectively.~~2021. The increase was due primarily ~~due~~ to ~~the purchase of fixed assets.~~

Other income and (expenses) for the three months ended September 30, 2017 and 2016, were $(3,603,099) and $(8,411,891), respectively. The decrease in other income and (expenses) was the result of a changean increase in loss ofon non-cash accounts associated with the change in fair value of the derivatives in the amount of ~~$4,724,151, commitment fees~~$47,405,884, with an overall increase in other expenses in the amount of ~~$51,919 and interest expense of $32,716, which includes non-cash amortization of debt discount of $(17,308).~~$382,034.

Our net loss increased by $47,468,166 to $(29,071,051) for the three months ended September 30, ~~2017 was $4,877,637,~~2022, compared to a net ~~loss~~income of ~~$9,016,618~~$18,397,115 for the three months ended September 30, 2016. The majority of the decrease in net loss was due primarily to a decrease in other expenses consisting of a decrease in loss in non-cash accounts associated with derivatives along with an increase in revenue, offset by a decrease in gross profit.

~~Results of Operations for the nine months ended September 30, 2017 compared to the nine months ended September 30, 2016.~~

For the nine months ended September 30, 2017, we had revenue of $2,294,891 compared to $ 4,321,378 for the nine months ended September 30, 2016. Cost of sales for the nine months ended September 30, 2017, was $2,031,334 compared to $2,899,507 for the nine months ended September 30, 2016. Revenue decreased primarily due to PWT’s focus on marketing.

~~Our gross profit was $263,557 and $1,421,871 for the nine months ended September 30, 2017 and 2016, respectively.~~

For the nine months ended September 30, 2017, we had selling and marketing expenses of $2,165,213 compared to $1,419,566 for the nine months ended September 30, 2016. Selling and marketing expenses increased primarily due to an increase in investor relations and marketing expense.

General and administrative expenses decreased to $1,842,815 for the nine months ended September 30, 2017, compared to $1,860,239 for the nine months ended September 30, 2016. General and administrative expenses decreased primarily due to our overall expense reduction efforts.

Research and development cost for the nine months ended September 30, 2017 and 2016, were $136,582 and $447,034, respectively. The decrease in research and development costs was primarily due to a decrease in salaries, outside services and other research and development costs.

~~Depreciation expense for the nine months ended September 30, 2017 and 2016, was $39,506 and $33,902, respectively. The increase was primarily due to the purchase of fixed assets.~~

Other income (expense) for the nine months ended September 30, 2017 and 2016, was $(4,739,243) and $(3,389,184), respectively. The increase in other expenses was primarily a result of a net change in loss of non-cash accounts associated with the fair value of the derivatives in the amount of $827,908, and a decrease in interest expense of $99,527 which includes non-cash amortization of debt discount of $(59,888), offset by an increase in commitment fees of $621,684.

~~Our net loss for the nine months ended September 30, 2017 was $8,659,802, compared to a net loss of $5,728,054 for the nine months ended September 30, 2016.~~2021. The majority of the increase in net loss was due primarily to an increase in other expenses ~~consisting~~associated with the net change in fair value of derivative instruments estimated each period. These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price, volatility, variable conversion prices based on market prices defined in the respective agreements and probabilities of certain outcomes based on managements’ estimates. These inputs are subject to significant changes from period to period, therefore, the estimated fair value of the derivative liabilities will fluctuate from period to period, and the fluctuation may be material.

Results of Operations for the nine months ended September 30, 2022 compared to the nine months ended September 30, 2021.

For the nine months ended September 30, 2022, we had revenue of $7,768,133 compared to $2,848,287 for the nine months ended September 30, 2021. The cost of sales for the nine months ended September 30, 2022 was $6,484,235 compared to $2,237,282 for the nine months ended September 30, 2021. Revenue and cost of sales increased primarily due to our subsidiary’s increase in revenue.

Our gross profit was $1,283,898 and $611,005 for the nine months ended September 30, 2022 and 2021, respectively.

For the nine months ended September 30, 2022, we had selling and marketing expenses of $1,825,170, compared to $2,201,045 for the nine months ended September 30, 2021. The decrease in selling and marketing expenses was primarily due to a decrease in marketing and investor relations expense.

General and administrative expenses were $2,900,203 for the nine months ended September 30, 2022, compared to $2,785,713 for the nine months ended September 30, 2021. The increase in general and administrative expenses was primarily due to an increase in professional and legal fees.

Other income and (expenses) increased by $24,467,149 to $(30,421,325) for the nine months ended September 30, 2022, compared to $(5,954,176) for the nine months ended September 30, 2021. The increase was due primarily to an increase in loss inon non-cash accounts associated with the change in fair value of the derivatives ~~and a~~in the amount of $25,029,945, with an overall decrease in ~~revenue~~other expenses in the amount of $562,796.

Our net loss for the nine months ended September 30, 2022 was $(33,894,246), compared to net loss of $(10,363,963) for the nine months ended September 30, 2021. The majority of the increase in net loss was due primarily to an increase in other expenses associated with the loss on net change in derivative instruments estimated each period. These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price, volatility, variable conversion prices based on market prices defined in the respective agreements and ~~gross profit.~~probabilities of certain outcomes based on managements’ estimates. These inputs are subject to significant changes from period to period, therefore, the estimated fair value of the derivative liabilities will fluctuate from period to period, and the fluctuation may be material.

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts receivable and accounts payable and capital expenditures.

The condensed consolidated financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying condensed consolidated financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company has not generated significant revenue, and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, raising additional ~~cash infusion.~~capital and increasing sales. We obtained funds from ~~our shareholders~~investors during the nine months ending September 30, 2017. Management believes the existing shareholders, the prospective new investors and future sales will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core business operations.2022. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain ~~undue~~ restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in case of equity financing.

In connection with our sale of Series M Preferred Stock conducted under Regulation A under the Securities Act, we may be subject to claims for rescission. If this occurs, it may have a negative effect on our liquidity.

At September 30, ~~2017~~2022 and December 31, ~~2016,~~2021, we had cash of ~~$342,164~~$1,751,226 and ~~$351,321,~~$706,421, including restricted cash of $1,266,391 and $433,951, respectively and a working capital deficit of ~~$12,090,561~~$37,858,994 and ~~$11,056,570,~~$12,826,008, respectively. The increase in working capital deficit was due primarily to an increase in non-cash derivative liabilities, ~~and convertible notes, contracts receivable, inventory assets,~~ accounts payable, contract assets, cash and accrued expenses, ~~billing in excess of cost, deferred income, and loan payable,~~ with a decrease in ~~cash, cost~~convertible promissory notes, contracts liabilities, loan payable and contract receivables.

During the period ended September 30, 2022, we raised an aggregate of $4,525,782 from the sale of preferred stock in ~~excess of billing~~private placements. Our ability to continue as a going concern is dependent upon raising capital from financing transactions and ~~prepaid expenses.~~future revenue.

Net cash used in operating activities was ~~$1,296,392~~$3,483,023 for the nine months ended September 30, ~~2017,~~2022, compared to ~~$910,129~~$3,560,033 for the prior period ended September 30, ~~2016.~~2021. The ~~increase~~decrease in cash used in operating activities was primarily due to a decrease in contract liabilities, contract assets, and prepaid expenses, with an increase in ~~cost of goods sold.~~ and accounts payable and accrued expenses.

Net cash flows used in investing activities was ~~$33,845~~$17,138 for the nine months ended September 30, ~~2017, as~~2022, compared to ~~$5,699~~$13,500 for the prior period ended September 30, ~~2016.~~2021. The ~~net~~ increase in cash used in investing activities was primarily due to ~~an increase in equipment purchases in~~the purchase of fixed assets during the current period.

Net cash flows provided by financing activities was ~~$1,321,122~~$4,554,966 for the nine months ended September 30, ~~2017,~~2022, as compared to ~~$1,088,217~~$3,716,241 for the ~~prior period~~nine months ended September 30, ~~2016.~~2021. The increase in cash provided by financing activities was due primarily to an increase in ~~equity financing through private placements.~~proceeds for issuance of preferred stock. To date we have principally financed our operations through the sale of our common and preferred stock and the issuance of debt.

We do not have any material commitments for capital expenditures during the next twelve months. Although our proceeds from the issuance of ~~equity~~securities together with revenue from operations are currently sufficient to fund our operating expenses in the near future, we will need to raise additional funds in the future so that we can maintain and expand our operations. Therefore, our future operations are dependent on our ability to secure additional ~~financing.~~financing, which may not be available on acceptable terms, or at all. Financing transactions may include the issuance of equity or debt securities, obtaining credit facilities, or other financing mechanisms. However, the trading price of our common stock and a downturn in the U.S. equity and debt markets could make it more difficult to obtain financing through the issuance of equity or debt securities. Even if we are able to raise the funds required, it is possible that we could incur unexpected costs and expenses, fail to collect significant amounts owed to us, or experience unexpected cash requirements that would force us to seek alternative financing. Furthermore, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. The inability to obtain additional capital may restrict our ability to grow and may reduce our ability to continue to conduct business operations. If we are unable to obtain additional financing, ~~or generate sufficient revenue,~~ we may have to curtail our marketing and development plans and possibly cease our operations.

We have estimated our current average burn, and believe that we have assets to ensure that we can function without liquidation ~~over the next twelve months,~~for a limited time, due to our cash on hand, growing revenue, and our ability to raise money from our investor base. Based on the aforesaid, we believe we have the ability to continue our operations for the ~~foreseeable~~immediate future and will be able to realize assets and discharge liabilities in the normal course of operations. However, there cannot be any assurance that any of the aforementioned assumptions will come to fruition and as such we may only be able to function for a short time.

We do not have any off balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues, and results of operations, liquidity or capital expenditures.

We are a smaller reporting company as defined by Rule 12b-2 of the ~~Securities~~ Exchange Act ~~of 1934~~ and are not required to provide the information under this item.

~~Pursuant to Rules 13a-15(b) and 15-d-15(b) under the Securities Exchange Act of 1934, as amended (“Exchange Act”), the Company~~We carried out an evaluation, under the supervision and with the participation of ~~the Company’s~~our management, including ~~the Company’s Chief Executive Officer~~our principal executive officer and ~~Chief Financial Officer (“CEO/CFO”)~~principal financial officer, of the effectiveness of ~~the Company’s~~our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)). Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the period covered byin this ~~report. The term “disclosure~~report, our disclosure controls and ~~procedures”, as defined under Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other~~ procedures ~~of a company that are designed~~were effective to ensure that information required to be disclosed ~~by a company~~ in ~~the~~ reports ~~that it files or submits~~filed under the Exchange Act, is recorded, processed, summarized and reported within the required time periods specified in the SEC’s rules and ~~forms. Disclosure controls~~forms and ~~procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act~~ is accumulated and communicated to ~~the company’s~~our management, including ~~its~~our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

As disclosed in our annual report filing for the year ended December 31, 2016, there was a significant deficiency in the Company’s internal control over financial reporting due to a lack of segregation of duties due to small Company staff size. Based upon the evaluation of the disclosure controls and procedures at the end of the period covered by this report, the Company’s CEO/CFO concluded that the Company’s disclosure controls and procedures were ineffective due to the significant deficiency in the Company’s internal control over financial reporting.

To address the significant deficiency, we performed additional analysis and other post-closing procedures in an effort to ensure our condensed consolidated financial statements included in this review report have been prepared in accordance with generally accepted accounting principles. Accordingly, management believes that the financial statements included in this quarterly report on Form 10-Q fairly present in all material respects our financial condition, results of operations and cash flows for the periods presented.

There were no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15f of the Exchange Act) that occurred during the ~~current period of 2017~~fiscal quarter ended September 30, 2021 that has materially affected, or are reasonably likely to materially affect, the ~~Company’s~~our internal control over financial reporting.

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

~~None~~There are no material updates to the litigation matters with C6 Capital, LLC nor Auctus Fund, LLC as previously disclosed in the Form 10-Q filed on August 15, 2022.

~~We are~~Not required for a smaller reporting ~~company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.~~company.

~~None~~As of the date of the filing of this report, the Company has 60 shares of Series F preferred stock outstanding which the Company failed to redeem on September 1, 2020, for an aggregate redemption price (equal to the stated value) of $60,000.

As of the date of the filing of this report, the Company has 25 shares of Series G preferred stock outstanding which the Company was required to, and failed to redeem on April 30, 2021, for an aggregate redemption price (equal to the stated value) of $25,000.

As of the date of the filing of this report, the Company has 25 shares of Series I preferred stock outstanding which the Company was required to, and failed to redeem between May 2, 2021 and June 10, 2021, for an aggregate redemption price (equal to the stated value) of $25,000.

As of the date of the filing of this report, the Company has 407 shares of Series K preferred stock outstanding which the Company was required to, and failed to redeem between August 5, 2021 and March 26, 2022, for an aggregate redemption price (equal to the stated value) of $407,150.

As previously reported, the Company has commenced an offering under Regulation 506c of Regulation D (the “Private Placement”) of the Securities Act of 1933, as amended (the “Securities Act”) pursuant to which the Company shall sell units of its securities (the “Units”) with each Unit consisting of (i) one restricted share of its common stock, (ii) a Class A Warrant to purchase one share of its common stock, (iii) a Class B Warrant to purchase one share of its common stock, (iv) a Class C Warrant to purchase one share of its common stock and (v) a Class D Warrant to purchase one share of its common stock to qualified investors. The Company may redeem the warrants, but only after one year from the investor’s initial subscription, and only if the average stock price over a ten day period after that time is double the applicable warrant’s exercise price. If accelerating, the Company must reduce each exercise price by 25%. The subscription documents contain a lock-up provision under which, subject to certain terms and conditions therein, the subscribers shall not sell any of their shares of common stock of the Company obtained in this Offering for a period of twelve months. The securities offered in the Private Placement will not be and have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

The securities referenced above were offered and sold pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act, and Rule 506(c) of Regulation D promulgated under the Securities Act.

~~Between October 31, 2017 and November 13, 2017, the Company issued to consultants an aggregate of 5,680,648 shares of the Company’s common stock in lieu of cash consideration.~~

~~The securities referenced above were offered and sold pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act.~~

~~In connection with certain one-time make good agreements, on October 31, 2017, the Company issued an aggregate of 399,328 shares of its common stock to certain holders of its common stock.~~

The securities above were offered and sold pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act since, among other things, the transactions did not involve a public offering.

On November 10, 2017, the Company entered into a Restricted Stock Grant Agreement (the “RSGA”) with Jean Louis Kindler, the Company’s Chief Commercial Officer and Director, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. The RSGA provides for the issuance of up to 2,000,000 shares of the Company’s common stock provided certain milestones are met in certain stages. All shares issuable under the RSGA are performance based shares and none have yet vested nor have any been issued.

	2.	Managing relationships with partners worldwide who are licensees and business partners.

	●3.	~~OriginClear’s Facebook Page (https://www.facebook.com/OriginClear)~~Developing the capability of partners to build systems and to deliver Operation & Maintenance (“O&M”) capability at scale, to support Water On Demand outsourced treatment and purification programs.

	4.	Continue to study the streamlining of water assets and royalties through the blockchain, as part of the $H2O™ concept. At this time there is no plan to actively develop a blockchain-based asset.

	5.	Prepare properties for eventual spinoff.

#	17Description	Patent No.	Date Patent Issued	Expiration Date
1	Wastewater System & Method	US 8,372,274 B2 Applications: WIPO, Mexico	02/12/13	07/16/31
2	Steel Reinforced HDPE Rainwater Harvesting	US 8,561,633 B2	10/22/13	05/16/32
3	Wastewater Treatment System CIP	US 8,871,089 B2	10/28/14	05/07/32
4	Scum Removal System for Liquids	US 9,205,353 B2	12/08/15	02/19/34
5	Portable, Steel Reinforced HDPE Pump Station CIP	US 9,217,244 B2	12/22/15	10/20/31

	18●	more durable: an estimated 75 to 100-year life cycle as opposed to a few decades for metal, or 40 to 50 years maximum for concrete;

	●	easier to manufacture: vessels manufacturing process can be automated; and

	●	recyclable and can be made out of biomaterials

Exhibit Number		Description of Exhibit

3131.1		Certification by Chief Executive Officer, ~~and~~required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act.*
31.2		Certification by Chief Financial Officer, required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act.*
3232.1		Certification byof Chief Executive Officer ~~and~~pursuant to 18 U.S.C. §1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
32.2		Certification of Chief Financial Officer ~~required by Rule 13a-14(b) or Rule 15d-14(b)~~pursuant to 18 U.S.C. §1350 as adopted pursuant to Section 906 of the ~~Exchange~~Sarbanes-Oxley Act ~~and Section 1350~~ of ~~Chapter 63 of Title 18 of the United States Code.~~2002.*
101.INS		Inline XBRL Instance Document.*
101.SCH		Inline XBRL Taxonomy Extension Schema.*
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase.*
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase.*
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase.*
101.PRE		Inline XBRL Extension Presentation Linkbase.*

November 15, 2022	ORIGINCLEAR, INC.

	~~By:~~	/s/ TT. Riggs Eckelberry
		TT. Riggs Eckelberry
		Chief Executive Officer
	(Principal Executive Officer) and

	September 30, 2017			December 31, 2016
	(Unaudited)
ASSETS

CURRENT ASSETS
Cash	$	342,164		$	351,321
Contracts receivable, less allowance for doubtful accounts of $50,000 and $50,000 respectively		523,548			382,895
Inventory		13,614			-
Cost in excess of billing		9,238			47,612
Work in progress		84,157			86,085
Prepaid expenses		17,991			42,128

TOTAL CURRENT ASSETS		990,712			910,041

NET PROPERTY AND EQUIPMENT		156,252			161,912

OTHER ASSETS
Other asset		19,538			19,538
Goodwill		682,145			682,145
Trademark		4,467			4,467
Security deposit		3,500			3,500
TOTAL OTHER ASSETS		709,650			709,650
TOTAL ASSETS	$	1,856,614		$	1,781,603

LIABILITIES AND SHAREHOLDERS’ DEFICIT

Current Liabilities
Accounts payable and other payable	$	830,539		$	480,064
Accrued expenses		847,114			715,281
Billing in excess of cost		233,394			-
Customer deposit		113,950			113,950
Warranty reserve		20,000			20,000
Loans payable, current portion		11,090			-
Derivative liabilities		10,728,464			8,702,083
Convertible promissory notes, net of discount of $54,440 and $591,835, respectively		296,722			1,935,233
Total Current Liabilities		13,081,273			11,966,611

Long Term Liabilities
Loan payable, long term portion		12,282			-
Convertible promissory notes, net of discount of $235,268 and $11,429, respectively		3,080,628			1,613,571
Total Long Term Liabilities		3,092,910			1,613,571
Total Liabilities		16,174,183			13,580,182

SHAREHOLDERS’ DEFICIT
Preferred stock, $0.0001 par value, 25,000,000 shares authorized 6,666 shares of Series B issued and outstanding, respectively		1			1
1,000 shares of Series C issued and outstanding, respectively		-			-
Common stock, $0.0001 par value, 300,000,000 shares authorized 78,151,781 and 21,428,454 equity shares issued and outstanding, respectively		7,815			2,143
Preferred treasury stock, 1,000 and 1,000 shares of Series C outstanding, respectively		-			-
Additional paid in capital		57,564,158			51,428,976
Accumulated other comprehensive loss		(134	)		(92	)
Accumulated deficit		(71,889,409	)		(63,229,607	)
TOTAL SHAREHOLDERS’ DEFICIT		(14,317,569	)		(11,798,579	)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	$	1,856,614		$	1,781,603

									Additional		Accumulated Other
	Preferred stock				Common stock				Paid-in		Comprehensive			Accumulated
	Shares		Amount		Shares		Amount		Capital		loss			Deficit			Total
Balance at December 31, 2016		7,666	$	1		21,433,571	$	2,143	$	51,428,976	$	(92	)	$	(63,229,607	)	$	(11,798,579	)

Common stock issuance for cash		-		-		10,775,722		1,078		1,296,672		-			-			1,297,750

Common stock issuance for conversion of debt		-		-		9,321,555		932		1,234,040		-			-			1,234,972

Common stock issuance for settlement of accounts payable		-		-		886,700		89		117,842		-			-			117,931

Common stock issued at fair value for services and commitment fees		-		-		35,734,233		3,573		3,415,025		-			-			3,418,598

Stock compensation cost		-		-		-		-		71,603		-			-			71,603

Other comprehensive loss		-		-		-		-		-		(42	)		-			(42	)

Net loss for the nine months ended September 30, 2017		-		-		-		-		-		-			(8,659,802	)		(8,659,802	)

Balance at September 30, 2017 (unaudited)		7,666	$	1		78,151,781	$	7,815	$	57,564,158	$	(134	)	$	(71,889,409	)	$	(14,317,569	)

	Nine Months Ended
	September 30, 2017			September 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(8,659,802	)	$	(5,728,054	)
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation and amortization		39,506			33,902
Common stock and warrants issued for services		3,418,598			1,787,902
Stock option and warrant compensation expense		71,603			155,112
Loss on net change in valuation of derivative liability and conversion of debt		2,787,138			1,959,230
Debt discount and original issue discount recognized as interest expense		313,546			373,434
Change in Assets (Increase) Decrease in:
Contracts receivable		(140,653	)		675,188
Cost in excess of billing		38,374			(12,954	)
Inventory asset		(13,614	)		-
Prepaid expenses		24,137			1,797
Work in progress		1,928			518
Other asset		-			(88,548	)
Change in Liabilities Increase (Decrease) in:
Accounts payable		468,406			299,584
Accrued expenses		121,047			257,501
Billing in excess of cost		209,294			(474,741	)
Deferred income		24,100			(150,000	)

NET CASH USED IN OPERATING ACTIVITIES		(1,296,392	)		(910,129	)

CASH FLOWS USED FROM INVESTING ACTIVITIES:
Purchase of fixed assets		(33,845	)		(5,699	)

CASH USED IN INVESTING ACTIVITIES		(33,845	)		(5,699	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Loans payable		23,372			-
Proceeds from convertible promissory notes		-			125,000
Proceeds for issuance of common stock for cash		1,297,750			963,217

NET CASH PROVIDED BY FINANCING ACTIVITIES		1,321,122			1,088,217

Foreign currency effect on cash flow		(42	)		(23	)

NET (DECREASE) INCREASE IN CASH		(9,157	)		172,366

CASH BEGINNING OF PERIOD		351,321			695,295

CASH END OF PERIOD	$	342,164		$	867,661

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	$	1,823		$	2,199
Taxes paid	$	-		$	-

SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Common stock issued at fair value for conversion of debt and accrued interest	$	1,234,972		$	878,040
Common stock issued at fair value on settlement of accounts payable	$	117,931		$	-
Common stock issued at fair value for supplemental shares	$	1,409,655		$	787,971
Beneficial conversion feature on convertible note	$	-		$	16,771
Conversion of accounts payable into a convertible note	$	-		$	430,896

Balance as of January 1, 2017	$	8,702,083
Fair Value of derivative liabilities issued		-
Change in derivative liability, excluding loss on settlement of debt		2,026,381
Balance as of September 30, 2017		10,728,464

Convertible Promissory Notes	$	3,667,068
Less debt discount		289,718
Convertible Promissory Notes, net of discount	$	3,377,350
Less current portion		296,722
Long term portion	$	3,080,628

	September 30, 2017
			Weighted
	Number of		average exercise
	Options		price
Outstanding, beginning of period		3,697,495	$	1.505
Granted		-		-
Exercised		-		-
Forfeited/Expired		-		-
Outstanding, end of period		3,697,495	$	1.505
Exercisable at the end of the period		2,682,644	$	1.035
Weighted average fair value of options granted during the period			$	-

						Weighted Average
		Stock		Stock		Remaining
Exercisable		Options		Options		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	6.65 - 147.00		52,276		50,401		4.84 - 7.02
$	10.15 - 15.40		32,362		32,362		5.96
$	1.31		3,612,857		2,599,881		3.22 - 4.05
			3,697,495		2,682,644

	September 30, 2017
				Weighted
	Number			average
	of			exercise
	Warrants			price
Outstanding-beginning of the period		506,026		$	5.25
Granted		22,825,000		$	0.02
Exercised		-			-
Forfeited		(27,296	)	$	(22.37	)
Outstanding - end of the period		23,303,730		$	0.13

	●	~~intellectual property;~~

	●	~~production;~~

	●	future operating results; and

	●
	●	plans, objectives, expectations, and intentions contained in this report that are not historical.

	/s/ Prasad Tare
		~~Acting Chief Financial Officer~~ ~~(Principal Accounting and Financial Officer)~~Prasad Tare
		Chief Financial Officer
		~~November 14, 2017~~(Principal Financial and Accounting Officer)